{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:25:15Z","timestamp":1787214315810,"version":"build-2736575974"},"reference-count":364,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04551-7","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:33:21Z","timestamp":1783654401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities"],"prefix":"10.1186","volume":"24","author":[{"given":"Fengshou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"4551_CR1","unstructured":"Global regional. and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u2009\u2013\u200980.10.1016\/s1474-4422(18)30499-x."},{"key":"4551_CR2","doi-asserted-by":"crossref","unstructured":"Gilmour GS, Nielsen G, Teodoro T, Yogarajah M, Coebergh JA, Dilley MD et al. Management of functional neurological disorder. J Neurol. 2020;267(7):2164\u2009\u2013\u200972.10.1007\/s00415-020-09772-w.","DOI":"10.1007\/s00415-020-09772-w"},{"key":"4551_CR3","doi-asserted-by":"crossref","unstructured":"Li S, Cheng C, Lu L, Ma X, Zhang X, Li A et al. Hearing Loss in Neurological Disorders. Front Cell Dev Biol. 2021;9:716300.10.3389\/fcell.2021.716300.","DOI":"10.3389\/fcell.2021.716300"},{"key":"4551_CR4","doi-asserted-by":"crossref","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145\u2009\u2013\u200958.10.1016\/s0140-6736(19)30427-1.","DOI":"10.1016\/S0140-6736(19)30427-1"},{"key":"4551_CR5","doi-asserted-by":"crossref","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021.10.1016\/j.jacc.2020.11.010.","DOI":"10.1016\/j.jacc.2020.11.021"},{"issue":"02","key":"4551_CR6","first-page":"233","volume":"27","author":"J YANG","year":"2024","unstructured":"YANG J, ZHANG Y, MA T, TIAN X, ZHAO Y. Epidemic status, disease burden and prediction of cardiovascular diseases in China, 1990\u20132019. Chin Gen Pract. 2024;27(02):233.","journal-title":"Chin Gen Pract"},{"key":"4551_CR7","doi-asserted-by":"crossref","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255\u2009\u2013\u200965.10.1016\/s1474-4422(19)30411-9.","DOI":"10.1016\/S1474-4422(19)30411-9"},{"key":"4551_CR8","doi-asserted-by":"publisher","first-page":"04160","DOI":"10.7189\/jogh.13.04160","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang Y, Li Y, Pan H, Han L. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. J global health. 2023;13:04160.","journal-title":"J global health"},{"key":"4551_CR9","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham PT, Shukla R, Khatri DK, Vora LK. Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier. Ageing Res Rev. 2024;101:102481. https:\/\/doi.org\/10.1016\/j.arr.2024.102481.","journal-title":"Ageing Res Rev"},{"key":"4551_CR10","doi-asserted-by":"crossref","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K et al. Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers. 2021;7(1):47.10.1038\/s41572-021-00280-3.","DOI":"10.1038\/s41572-021-00280-3"},{"issue":"3","key":"4551_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discovery. 2023;22(3):185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2.","journal-title":"Nat Rev Drug Discovery"},{"issue":"18","key":"4551_CR12","doi-asserted-by":"publisher","first-page":"10807","DOI":"10.3390\/ijms231810807","volume":"23","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Parayil R, Mishra S, Nongthomba U, Clement JP. Epilepsy Characteristics in Neurodevelopmental Disorders: Research from Patient Cohorts and Animal Models Focusing on Autism Spectrum Disorder. Int J Mol Sci [Internet]. 2022;23(18):10807.","journal-title":"Int J Mol Sci [Internet]"},{"key":"4551_CR13","doi-asserted-by":"publisher","unstructured":"Murphy SJ, Werring DJ. Stroke: causes and clinical features. Med (Abingdon). 2020;48(9):561\u20136. https:\/\/doi.org\/10.1016\/j.mpmed.2020.06.002.","DOI":"10.1016\/j.mpmed.2020.06.002"},{"issue":"1","key":"4551_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","volume":"10","author":"I Boutitah-Benyaich","year":"2025","unstructured":"Boutitah-Benyaich I, Eixarch H, Villacieros-\u00c1lvarez J, Hervera A, Cobo-Calvo \u00c1, Montalban X, et al. Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduct Target Therapy. 2025;10(1):324\u2013s10103841392.","journal-title":"Signal Transduct Target Therapy"},{"key":"4551_CR15","doi-asserted-by":"crossref","unstructured":"Cullinane PW, Wrigley S, Bezerra Parmera J, Valerio F, Millner TO, Shaw K et al. Pathology of neurodegenerative disease for the general neurologist. Practical Neurology. 2024;24(3):188.10.1136\/pn-2023-003988.","DOI":"10.1136\/pn-2023-003988"},{"key":"4551_CR16","doi-asserted-by":"crossref","unstructured":"Hemphill Matthew A, Dauth S, Yu Chung J, Dabiri Borna E, Parker Kevin K. Traumatic Brain Injury and the Neuronal Microenvironment: A Potential Role for Neuropathological Mechanotransduction. Neuron. 2015;85(6):1177\u2009\u2013\u200992.10.1016\/j.neuron.2015.02.041.","DOI":"10.1016\/j.neuron.2015.02.041"},{"key":"4551_CR17","doi-asserted-by":"publisher","unstructured":"Wilson DM III, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032.","DOI":"10.1016\/j.cell.2022.12.032"},{"key":"4551_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-4020-9434-7_11","volume-title":"Protein Folding and Misfolding: Neurodegenerative Diseases","author":"GG Kovacs","year":"2009","unstructured":"Kovacs GG, Budka H. Protein-Based Neuropathology and Molecular Classification of Human Neurodegenerative Diseases. In: Ov\u00e1di J, Orosz F, editors. Protein Folding and Misfolding: Neurodegenerative Diseases. Dordrecht: Springer Netherlands; 2009. pp. 251\u201372."},{"key":"4551_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.osep.2025.08.001","volume":"8","author":"IJ Moore","year":"2025","unstructured":"Moore IJ, Embry E, Balloun B, Keller H, Magnante C, Padala KP, et al. The Relationship of Neuropsychiatric Symptoms, Cognitive Dysfunction and Functional Decline in Older Adults. Am J Geriatric Psychiatry: Open Sci Educ Pract. 2025;8:1\u20136. https:\/\/doi.org\/10.1016\/j.osep.2025.08.001.","journal-title":"Am J Geriatric Psychiatry: Open Sci Educ Pract"},{"key":"4551_CR20","doi-asserted-by":"crossref","unstructured":"Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: new subtypes and shared mechanisms. The Lancet Neurology. 2022;21(6):537\u2009\u2013\u200950.10.1016\/S1474-4422(21)00422-1.","DOI":"10.1016\/S1474-4422(21)00422-1"},{"issue":"3","key":"4551_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/ijms23031217","volume":"23","author":"A Morozova","year":"2022","unstructured":"Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Soloveva K, et al. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Int J Mol Sci [Internet]. 2022;23(3):1217.","journal-title":"Int J Mol Sci [Internet]"},{"key":"4551_CR22","doi-asserted-by":"crossref","unstructured":"Wennberg AMV, Wu MN, Rosenberg PB, Spira AP. Sleep Disturbance, Cognitive Decline, and Dementia: A Review. Semin Neurol. 2017;37(4):395-406.10.1055\/s-0037-1604351.","DOI":"10.1055\/s-0037-1604351"},{"issue":"2","key":"4551_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.25259\/JNRP_456_2023","volume":"15","author":"A Kushwaha","year":"2024","unstructured":"Kushwaha A, Basera DS, Kumari S, Sutar RF, Singh V, Das S, et al. Assessment of memory deficits in psychiatric disorders: a systematic literature review. J Neurosciences Rural Pract. 2024;15(2):182.","journal-title":"J Neurosciences Rural Pract"},{"key":"4551_CR24","doi-asserted-by":"crossref","unstructured":"Asprec L. The impact of sleep deprivation in nurses on psychomotor skills, memory, and medical errors. 2023.","DOI":"10.33015\/dominican.edu\/2023.NURS.ST.06"},{"issue":"6","key":"4551_CR25","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3390\/jcm14062122","volume":"14","author":"A Korchut","year":"2025","unstructured":"Korchut A, Sternal D, Krzemi\u0144ska S, Marcisz-Dyla E, B\u0105k E. Cognitive and Psychomotor Performance of Patients After Ischemic Stroke Undergoing Early and Late Rehabilitation. J Clin Med [Internet]. 2025;14(6):2122.","journal-title":"J Clin Med [Internet]"},{"issue":"4","key":"4551_CR26","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1002\/alz.13715","volume":"20","author":"ZN Sayyid","year":"2024","unstructured":"Sayyid ZN, Wang H, Cai Y, Gross AL, Swenor BK, Deal JA, et al. Sensory and motor deficits as contributors to early cognitive impairment. Alzheimer\u2019s Dement. 2024;20(4):2653\u201361.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"6","key":"4551_CR27","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/s41380-025-02911-7","volume":"30","author":"J Hardy","year":"2025","unstructured":"Hardy J, Escott-Price V. The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure. Mol Psychiatry. 2025;30(6):2748\u201353. https:\/\/doi.org\/10.1038\/s41380-025-02911-7.","journal-title":"Mol Psychiatry"},{"key":"4551_CR28","doi-asserted-by":"publisher","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565\u201381. https:\/\/doi.org\/10.1038\/s41582-019-0244-7.","DOI":"10.1038\/s41582-019-0244-7"},{"issue":"1","key":"4551_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Therapy. 2022;7(1):391\u2013s10103841392.","journal-title":"Signal Transduct Target Therapy"},{"key":"4551_CR30","doi-asserted-by":"publisher","unstructured":"Sekiya H, Matsubara T, DeTure MA, Dickson DW. Neuropathology of Lewy body dementia: Lewy-related pathology, \u03b1-synuclein oligomers, and comorbid pathologies. Mol Neurodegener. 2025;20(1):117. https:\/\/doi.org\/10.1186\/s13024-025-00900-6.","DOI":"10.1186\/s13024-025-00900-6"},{"issue":"11","key":"4551_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.mpdhp.2016.10.009","volume":"22","author":"WW Pendlebury","year":"2016","unstructured":"Pendlebury WW. The neuropathology of neurodegenerative diseases causing dementia. Diagn Histopathology. 2016;22(11):424\u201330. https:\/\/doi.org\/10.1016\/j.mpdhp.2016.10.009.","journal-title":"Diagn Histopathology"},{"issue":"7628","key":"4551_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539(7628):180\u20136. https:\/\/doi.org\/10.1038\/nature20411.","journal-title":"Nature"},{"issue":"2","key":"4551_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuron.2013.01.002","volume":"77","author":"W Jagust","year":"2013","unstructured":"Jagust W. Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration. Neuron. 2013;77(2):219. https:\/\/doi.org\/10.1016\/j.neuron.2013.01.002.","journal-title":"Neuron"},{"key":"4551_CR34","doi-asserted-by":"publisher","unstructured":"Mohs RC, Greig NH. Drug discovery and development: Role of basic biological research. Alzheimers Dement (N Y). 2017;3(4):651\u20137. https:\/\/doi.org\/10.1016\/j.trci.2017.10.005.","DOI":"10.1016\/j.trci.2017.10.005"},{"key":"4551_CR35","doi-asserted-by":"publisher","first-page":"1201419","DOI":"10.3389\/fddsv.2023.1201419","volume":"3","author":"N Singh","year":"2023","unstructured":"Singh N, Vayer P, Tanwar S, Poyet J-L, Tsaioun K, Villoutreix BO. Drug discovery and development: introduction to the general public and patient groups. Front Drug Discovery. 2023;3:1201419.","journal-title":"Front Drug Discovery"},{"key":"4551_CR36","doi-asserted-by":"publisher","unstructured":"DiMasi JA. Research and Development Costs of New Drugs. JAMA. 2020;324(5):517. https:\/\/doi.org\/10.1001\/jama.2020.8648.","DOI":"10.1001\/jama.2020.8648"},{"key":"4551_CR37","doi-asserted-by":"publisher","unstructured":"Wouters OJ, McKee M, Luyten J. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009\u20132018. JAMA. 2020;323(9):844\u201353. https:\/\/doi.org\/10.1001\/jama.2020.1166.","DOI":"10.1001\/jama.2020.1166"},{"issue":"7","key":"4551_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","volume":"18","author":"H Dowden","year":"2019","unstructured":"Dowden H, Munro J. Trends in clinical success rates and therapeutic focus. Nat Rev Drug Discov. 2019;18(7):495\u20136. https:\/\/doi.org\/10.1038\/d41573-019-00074-z.","journal-title":"Nat Rev Drug Discov"},{"key":"4551_CR39","doi-asserted-by":"crossref","unstructured":"Takebe T, Imai R, Ono S. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development. Clin Transl Sci. 2018;11(6):597-606.10.1111\/cts.12577.","DOI":"10.1111\/cts.12577"},{"issue":"7","key":"4551_CR40","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022;12(7):3049\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2022.02.002.","journal-title":"Acta Pharm Sin B"},{"key":"4551_CR41","doi-asserted-by":"crossref","unstructured":"Yu DT, Li RX, Sun JR, Rong XW, Guo XG, Zhu GD. Global mortality, prevalence and disability-adjusted life years of Alzheimer\u2019s disease and other dementias in adults aged 60 years or older, and the impact of the COVID-19 pandemic: a comprehensive analysis for the global burden of disease 2021. BMC Psychiatry. 2025;25(1):503.10.1186\/s12888-025-06661-2.","DOI":"10.1186\/s12888-025-06661-2"},{"issue":"4","key":"4551_CR42","doi-asserted-by":"publisher","first-page":"e095610","DOI":"10.1136\/bmjopen-2024-095610","volume":"15","author":"M Li","year":"2025","unstructured":"Li M, Ye X, Huang Z, Ye L, Chen C. Global burden of Parkinson\u2019s disease from 1990 to 2021: a population-based study. BMJ Open. 2025;15(4):e095610. https:\/\/doi.org\/10.1136\/bmjopen-2024-095610.","journal-title":"BMJ Open"},{"key":"4551_CR43","doi-asserted-by":"crossref","unstructured":"Khan G, Hashim MJ. Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections. Journal of Epidemiology and Global Health. 2025;15(1):21.10.1007\/s44197-025-00353-6.","DOI":"10.1007\/s44197-025-00353-6"},{"key":"4551_CR44","doi-asserted-by":"crossref","unstructured":"Wolfson C, Gauvin DE, Ishola F, Oskoui M. Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review. Neurology. 2023;101(6):e613-e23.10.1212\/wnl.0000000000207474.","DOI":"10.1212\/WNL.0000000000207474"},{"issue":"4","key":"4551_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/wco.0000000000001376","volume":"38","author":"A Madera","year":"2025","unstructured":"Madera A, Schrodt C, Mendizabal A. Disparities in Huntington\u2019s disease care and research. Curr Opin Neurol. 2025;38(4):337\u201342. https:\/\/doi.org\/10.1097\/wco.0000000000001376.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"4551_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/picr.picr_70_24","volume":"16","author":"K Saranraj","year":"2025","unstructured":"Saranraj K, Kiran PU. Drug repurposing: Clinical practices and regulatory pathways. Perspect Clin Res. 2025;16(2):61\u20138. https:\/\/doi.org\/10.4103\/picr.picr_70_24.","journal-title":"Perspect Clin Res"},{"key":"4551_CR47","doi-asserted-by":"crossref","unstructured":"Nossier ES, Anwar MM, El-Zahabi MA. Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches. Molecular Diversity. 2025.10.1007\/s11030-025-11248-w.","DOI":"10.1007\/s11030-025-11248-w"},{"issue":"1","key":"4551_CR48","doi-asserted-by":"publisher","first-page":"e70049","DOI":"10.1002\/prp2.70049","volume":"13","author":"S Akinbolade","year":"2025","unstructured":"Akinbolade S, Fairbairn R, Inskip A, Potter R, Oliver A, Craig D. Repurposed Medicines: A Scan of the Non-commercial Clinical Research Landscape. Pharmacol Res Perspect. 2025;13(1):e70049.","journal-title":"Pharmacol Res Perspect"},{"key":"4551_CR49","doi-asserted-by":"publisher","unstructured":"Srikanth G, Prasad Beda D, Praveen Kumar N. Repurposed Drugs: Current Trends in Drug Discovery [Internet]. Pharmaceutical Science. IntechOpen; 2024. https:\/\/doi.org\/10.5772\/intechopen.1006501.","DOI":"10.5772\/intechopen.1006501"},{"issue":"1","key":"4551_CR50","doi-asserted-by":"publisher","first-page":"20240013","DOI":"10.58647\/DRUGREPO.24.1.0013","volume":"1","author":"BA Pauly","year":"2024","unstructured":"Pauly BA. Accelerating drug development: unleashing the power of drug repurposing. Drug Repurposing. 2024;1(1):20240013.","journal-title":"Drug Repurposing"},{"key":"4551_CR51","doi-asserted-by":"publisher","first-page":"100713","DOI":"10.1016\/j.drup.2020.100713","volume":"52","author":"J Dini\u0107","year":"2020","unstructured":"Dini\u0107 J, Efferth T, Garc\u00eda-Sosa AT, Grahovac J, Padr\u00f3n JM, Pajeva I, et al. Repurposing old drugs to fight multidrug resistant cancers. Drug Resist Updates. 2020;52:100713. https:\/\/doi.org\/10.1016\/j.drup.2020.100713.","journal-title":"Drug Resist Updates"},{"key":"4551_CR52","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduction and Targeted Therapy. 2020;5(1):113.10.1038\/s41392-020-00213-8.","DOI":"10.1038\/s41392-020-00213-8"},{"issue":"11","key":"4551_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41569-022-00717-6","volume":"19","author":"M Abdelsayed","year":"2022","unstructured":"Abdelsayed M, Kort EJ, Jovinge S, Mercola M. Repurposing drugs to treat cardiovascular disease in the era of precision medicine. Nat Rev Cardiol. 2022;19(11):751\u201364. https:\/\/doi.org\/10.1038\/s41569-022-00717-6.","journal-title":"Nat Rev Cardiol"},{"key":"4551_CR54","unstructured":"Hogan AE, Davis C, Jenkins BJ, Jones N, O\u2019Shea D. Repurposing metabolic drugs as anti-inflammatory agents. Trends in Endocrinology & Metabolism.10.1016\/j.tem.2025.07.003."},{"key":"4551_CR55","doi-asserted-by":"crossref","unstructured":"Bui N-L, Hoang D-A, Ho Q-A, Nguyen Thi T-N, Singh V, Chu D-T. Chapter Twelve - Drug repurposing for metabolic disorders: Scientific, technological and economic issues. In: Singh V, editor. Progress in Molecular Biology and Translational Science. Volume 207. Academic; 2024. pp. 321\u201336.","DOI":"10.1016\/bs.pmbts.2024.02.006"},{"issue":"18","key":"4551_CR56","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2174\/15680266113136660166","volume":"13","author":"J Finsterer","year":"2013","unstructured":"Finsterer J, Frank M. Repurposed drugs in metabolic disorders. Curr Top Med Chem. 2013;13(18):2386\u201394. https:\/\/doi.org\/10.2174\/15680266113136660166.","journal-title":"Curr Top Med Chem"},{"key":"4551_CR57","doi-asserted-by":"publisher","unstructured":"Clout AE, Della Pasqua O, Hanna MG, Orlu M, Pitceathly RDS. Drug repurposing in neurological diseases: an integrated approach to reduce trial and error. J Neurol Neurosurg Psychiatry. 2019;90(11):1270\u20135. https:\/\/doi.org\/10.1136\/jnnp-2019-320879.","DOI":"10.1136\/jnnp-2019-320879"},{"key":"4551_CR58","doi-asserted-by":"crossref","unstructured":"Hussain MS, Mir PA, Kumar N, Mohi-Ud-Din R, Wali AF, Mir RH et al. From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases. Adv Pharmacol Pharm Sci. 2025;2025:1070716.10.1155\/adpp\/1070716.","DOI":"10.1155\/adpp\/1070716"},{"issue":"7","key":"4551_CR59","doi-asserted-by":"publisher","first-page":"104390","DOI":"10.1016\/j.drudis.2025.104390","volume":"30","author":"A Recino","year":"2025","unstructured":"Recino A, Rayner MLD, Rohn JL, Della Pasqua O, Recino A, Rayner MLD, et al. Therapeutic innovation in drug repurposing: Challenges and opportunities. Drug Discovery Today. 2025;30(7):104390. https:\/\/doi.org\/10.1016\/j.drudis.2025.104390.","journal-title":"Drug Discovery Today"},{"key":"4551_CR60","doi-asserted-by":"publisher","unstructured":"Cousins HC, Nayar G, Altman RB. Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities. Annu Rev Biomed Data Sci. 2024;7(1):15-29. https:\/\/doi.org\/10.1146\/annurev-biodatasci-110123-025333.","DOI":"10.1146\/annurev-biodatasci-110123-025333"},{"key":"4551_CR61","doi-asserted-by":"crossref","unstructured":"Breckenridge A, Jacob R. Overcoming the legal and regulatory barriers to drug repurposing. Nat Rev Drug Discov. 2019;18(1):1-2.10.1038\/nrd.2018.92.","DOI":"10.1038\/nrd.2018.92"},{"issue":"1","key":"4551_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discovery. 2019;18(1):41\u201358.","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"4551_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bph.70243","volume":"183","author":"ZI Petyk\u00f3","year":"2026","unstructured":"Petyk\u00f3 ZI, Hossz\u00fa D, Csan\u00e1di M, Gy\u00f6ngy\u00f6si K, Obeng GD, Ameyaw D, et al. The eyes of the beholder: Perceived barriers to successful drug repurposing. Br J Pharmacol. 2026;183(2):219\u201333.","journal-title":"Br J Pharmacol"},{"key":"4551_CR64","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.crchbi.2023.100042","volume":"3","author":"L Cai","year":"2023","unstructured":"Cai L, Chu J, Xu J, Meng Y, Lu C, Tang X, et al. Machine learning for drug repositioning: Recent advances and challenges. Curr Res Chem Biology. 2023;3:100042. https:\/\/doi.org\/10.1016\/j.crchbi.2023.100042.","journal-title":"Curr Res Chem Biology"},{"key":"4551_CR65","doi-asserted-by":"crossref","unstructured":"Liu R, Wei L, Zhang P. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nature Machine Intelligence. 2021;3(1):68-75.10.1038\/s42256-020-00276-w.","DOI":"10.1038\/s42256-020-00276-w"},{"key":"4551_CR66","doi-asserted-by":"crossref","unstructured":"Wang ZP, Li X, Matsumoto N, Venkatesan M, Chang J-H, Moran J et al. Drug repurposing for Alzheimer\u2019s disease using a graph-of-thoughts based large language model to infer drug-disease relationships in a comprehensive knowledge graph. BioData Mining. 2025;18(1):51.10.1186\/s13040-025-00466-5.","DOI":"10.1186\/s13040-025-00466-5"},{"key":"4551_CR67","doi-asserted-by":"crossref","unstructured":"Doshi S, Chepuri SP. A computational approach to drug repurposing using graph neural networks. Comput Biol Med. 2022;150:105992.10.1016\/j.compbiomed.2022.105992.","DOI":"10.1016\/j.compbiomed.2022.105992"},{"key":"4551_CR68","doi-asserted-by":"crossref","unstructured":"Nam Y, Kim M, Chang HS, Shin H. Drug repurposing with network reinforcement. BMC Bioinformatics. 2019;20(Suppl 13):383.10.1186\/s12859-019-2858-6.","DOI":"10.1186\/s12859-019-2858-6"},{"key":"4551_CR69","doi-asserted-by":"crossref","unstructured":"Yang F, Zhang Q, Ji X, Zhang Y, Li W, Peng S et al. Machine Learning Applications in Drug Repurposing. Interdiscip Sci. 2022;14(1):15-21.10.1007\/s12539-021-00487-8.","DOI":"10.1007\/s12539-021-00487-8"},{"key":"4551_CR70","doi-asserted-by":"crossref","unstructured":"Amiri R, Razmara J, Parvizpour S, Izadkhah H. A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks. BMC Bioinformatics. 2023;24(1):442.10.1186\/s12859-023-05572-x.","DOI":"10.1186\/s12859-023-05572-x"},{"key":"4551_CR71","doi-asserted-by":"crossref","unstructured":"Huang K, Chandak P, Wang Q, Havaldar S, Vaid A, Leskovec J et al. A foundation model for clinician-centered drug repurposing. Nature Medicine. 2024;30(12):3601\u2009\u2013\u200913.10.1038\/s41591-024-03233-x.","DOI":"10.1038\/s41591-024-03233-x"},{"key":"4551_CR72","doi-asserted-by":"crossref","unstructured":"Liao Q, Zhang Y, Chu Y, Ding Y, Liu Z, Zhao X et al. Application of Artificial Intelligence In Drug-target Interactions Prediction: A Review. npj Biomedical Innovations. 2025;2(1):1.10.1038\/s44385-024-00003-9.","DOI":"10.1038\/s44385-024-00003-9"},{"key":"4551_CR73","doi-asserted-by":"crossref","unstructured":"Odah M. Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular Design. 2025.","DOI":"10.20944\/preprints202503.0912.v1"},{"key":"4551_CR74","doi-asserted-by":"crossref","unstructured":"Raikar AS, Andrew J, Dessai PP, Prabhu SM, Jathar S, Prabhu A et al. Neuromorphic computing for modeling neurological and psychiatric disorders: implications for drug development. Artificial Intelligence Review. 2024;57(12):318.10.1007\/s10462-024-10948-3.","DOI":"10.1007\/s10462-024-10948-3"},{"key":"4551_CR75","doi-asserted-by":"publisher","first-page":"1396520","DOI":"10.3389\/fneur.2024.1396520","volume":"15","author":"L Negro-Demontel","year":"2024","unstructured":"Negro-Demontel L, Maleki AF, Reich DS, Kemper C. The complement system in neurodegenerative and inflammatory diseases of the central nervous system. Front Neurol. 2024;15:1396520.","journal-title":"Front Neurol"},{"issue":"6753","key":"4551_CR76","doi-asserted-by":"publisher","first-page":"eadx0043","DOI":"10.1126\/science.adx0043","volume":"388","author":"F-D Shi","year":"2025","unstructured":"Shi F-D, Yong VW. Neuroinflammation across neurological diseases. Science. 2025;388(6753):eadx0043. https:\/\/doi.org\/10.1126\/science.adx0043.","journal-title":"Science"},{"key":"4551_CR77","doi-asserted-by":"crossref","unstructured":"Kesidou E, Theotokis P, Damianidou O, Boziki M, Konstantinidou N, Taloumtzis C et al. CNS Ageing in Health and Neurodegenerative Disorders. J Clin Med. 2023;12(6).10.3390\/jcm12062255.","DOI":"10.3390\/jcm12062255"},{"key":"4551_CR78","doi-asserted-by":"crossref","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduction and Targeted Therapy. 2023;8(1):359.10.1038\/s41392-023-01588-0.","DOI":"10.1038\/s41392-023-01588-0"},{"key":"4551_CR79","doi-asserted-by":"crossref","unstructured":"Dias-Carvalho A, S\u00e1 SI, Carvalho F, Fernandes E, Costa VM. Inflammation as common link to progressive neurological diseases. Archives of Toxicology. 2024;98(1):95-119.10.1007\/s00204-023-03628-8.","DOI":"10.1007\/s00204-023-03628-8"},{"key":"4551_CR80","doi-asserted-by":"crossref","unstructured":"Ningrum DNA, Kung WM. Challenges and Perspectives of Neurological Disorders. Brain Sci. 2023;13(4).10.3390\/brainsci13040676.","DOI":"10.3390\/brainsci13040676"},{"key":"4551_CR81","doi-asserted-by":"crossref","unstructured":"Domaradzki J, Jabkowski P, Walkowiak D. Rare disease, common struggles: quality of life, caregiver burden and financial wellbeing of family caregivers in Poland. Scientific Reports. 2025;15(1):22678.10.1038\/s41598-025-08866-7.","DOI":"10.1038\/s41598-025-08866-7"},{"key":"4551_CR82","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, et al. Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev. 2024;99:102357. https:\/\/doi.org\/10.1016\/j.arr.2024.102357.","journal-title":"Ageing Res Rev"},{"key":"4551_CR83","doi-asserted-by":"crossref","unstructured":"Lindholm P, Saarma M. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Molecular Psychiatry. 2022;27(3):1310\u2009\u2013\u200921.10.1038\/s41380-021-01394-6.","DOI":"10.1038\/s41380-021-01394-6"},{"key":"4551_CR84","doi-asserted-by":"crossref","unstructured":"Aaseth J, Dusek P, Roos PM. Prevention of progression in Parkinson\u2019s disease. BioMetals. 2018;31(5):737\u2009\u2013\u200947.10.1007\/s10534-018-0131-5.","DOI":"10.1007\/s10534-018-0131-5"},{"key":"4551_CR85","doi-asserted-by":"publisher","first-page":"572090","DOI":"10.3389\/fnagi.2020.572090","volume":"12","author":"K Mayne","year":"2020","unstructured":"Mayne K, White JA, McMurran CE, Rivera FJ, de la Fuente AG. Aging and neurodegenerative disease: is the adaptive immune system a friend or foe? Front Aging Neurosci. 2020;12:572090.","journal-title":"Front Aging Neurosci"},{"key":"4551_CR86","doi-asserted-by":"crossref","unstructured":"Tran J, Anastacio H, Bardy C. Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells. npj Parkinson\u2019s Disease. 2020;6(1):8.10.1038\/s41531-020-0110-8.","DOI":"10.1038\/s41531-020-0110-8"},{"key":"4551_CR87","doi-asserted-by":"crossref","unstructured":"Roy K, Syed M, Narad P, Sengupta A. Chapter Two - Genetic and epigenetic drivers of neurodegenerative disorders. In: Ahmad SR, editor. Progress in Brain Research. Volume 297. Elsevier; 2025. pp. 53\u2013130.","DOI":"10.1016\/bs.pbr.2025.08.002"},{"key":"4551_CR88","doi-asserted-by":"crossref","unstructured":"Dunn AR, O\u2019Connell KMS, Kaczorowski CC. Gene-by-environment interactions in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neurosci Biobehav Rev. 2019;103:73-80.10.1016\/j.neubiorev.2019.06.018.","DOI":"10.1016\/j.neubiorev.2019.06.018"},{"key":"4551_CR89","doi-asserted-by":"crossref","unstructured":"Wang H, Yang F, Zhang S, Xin R, Sun Y. Genetic and environmental factors in Alzheimer\u2019s and Parkinson\u2019s diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis. 2021;7(1):70.10.1038\/s41531-021-00213-7.","DOI":"10.1038\/s41531-021-00213-7"},{"issue":"2","key":"4551_CR90","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"key":"4551_CR91","doi-asserted-by":"crossref","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nature Neuroscience. 2016;19(8):1085\u2009\u2013\u200992.10.1038\/nn.4328.","DOI":"10.1038\/nn.4328"},{"issue":"1","key":"4551_CR92","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"key":"4551_CR93","doi-asserted-by":"crossref","unstructured":"Ulland TK, Song WM, Huang SC-C, Ulrich JD, Sergushichev A, Beatty WL, et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell. 2017;170(4):649\u2009\u2013\u200963.e13.10.1016\/j.cell.2017.07.023.","DOI":"10.1016\/j.cell.2017.07.023"},{"key":"4551_CR94","doi-asserted-by":"crossref","unstructured":"Vitek JL, Jain R, Chen L, Tr\u00f6ster AI, Schrock LE, House PA et al. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson\u2019s disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. The Lancet Neurology. 2020;19(6):491-501.10.1016\/S1474-4422(20)30108-3.","DOI":"10.1016\/S1474-4422(20)30108-3"},{"key":"4551_CR95","doi-asserted-by":"crossref","unstructured":"Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study. The Lancet Neurology. 2014;13(2):141\u2009\u2013\u20099.10.1016\/S1474-4422(13)70293-X.","DOI":"10.1016\/S1474-4422(13)70293-X"},{"key":"4551_CR96","doi-asserted-by":"crossref","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M, et al. Parkinson\u2019s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell. 2016;166(2):314\u2009\u2013\u200927.10.1016\/j.cell.2016.05.039.","DOI":"10.1016\/j.cell.2016.05.039"},{"key":"4551_CR97","doi-asserted-by":"crossref","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H et al. Prion-like spreading of pathological \u03b1-synuclein in brain. Brain. 2013;136(4):1128\u2009\u2013\u200938.10.1093\/brain\/awt037.","DOI":"10.1093\/brain\/awt037"},{"key":"4551_CR98","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2022.07.007","volume":"101","author":"Y Feng","year":"2022","unstructured":"Feng Y, Wei Z-H, Liu C, Li G-Y, Qiao X-Z, Gan Y-J, et al. Genetic variations in GABA metabolism and epilepsy. Seizure: Eur J Epilepsy. 2022;101:22\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2022.07.007.","journal-title":"Seizure: Eur J Epilepsy"},{"key":"4551_CR99","doi-asserted-by":"publisher","first-page":"106890","DOI":"10.1016\/j.eplepsyres.2022.106890","volume":"181","author":"LH Nguyen","year":"2022","unstructured":"Nguyen LH, Leiser SC, Song D, Brunner D, Roberds SL, Wong M, et al. Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex. Epilepsy Res. 2022;181:106890.","journal-title":"Epilepsy Res"},{"issue":"sup1","key":"4551_CR100","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/21678421.2017.1362000","volume":"18","author":"Group WGoBotEAS","year":"2017","unstructured":"Group WGoBotEAS. Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degeneration. 2017;18(sup1):20\u201331.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"issue":"12","key":"4551_CR101","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","volume":"387","author":"TM Miller","year":"2022","unstructured":"Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2022;387(12):1099\u2013110.","journal-title":"N Engl J Med"},{"issue":"9","key":"4551_CR102","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","volume":"24","author":"E Conicella Alexander","year":"2016","unstructured":"Conicella Alexander E, Zerze G\u00fcl H, Mittal J, Fawzi Nicolas L. ALS Mutations Disrupt Phase Separation Mediated by \u03b1-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016;24(9):1537\u201349. https:\/\/doi.org\/10.1016\/j.str.2016.07.007.","journal-title":"Structure"},{"key":"4551_CR103","unstructured":"Renton Alan E, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs JR et al. A Hexanucleotide Repeat Expansion in <\u2009em>C9ORF72\u2009Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72(2):257\u2009\u2013\u200968.10.1016\/j.neuron.2011.09.010."},{"key":"4551_CR104","doi-asserted-by":"crossref","unstructured":"Bellut M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK. Delayed NLRP3 inflammasome inhibition ameliorates subacute stroke progression in mice. Journal of Neuroinflammation. 2023;20(1):4.10.1186\/s12974-022-02674-w.","DOI":"10.1186\/s12974-022-02674-w"},{"key":"4551_CR105","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbi.2020.12.009","volume":"92","author":"M Franke","year":"2021","unstructured":"Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK, Brain. Behav Immun. 2021;92:221\u201331. https:\/\/doi.org\/10.1016\/j.bbi.2020.12.009.","journal-title":"Behav Immun"},{"issue":"17","key":"4551_CR106","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","volume":"378","author":"BC Campbell","year":"2018","unstructured":"Campbell BC, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018;378(17):1573\u201382.","journal-title":"N Engl J Med"},{"issue":"1","key":"4551_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"4551_CR108","doi-asserted-by":"crossref","unstructured":"Group HS. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. JAMA. 2016;316(1):40-50.10.1001\/jama.2016.8655.","DOI":"10.1001\/jama.2016.8011"},{"issue":"24","key":"4551_CR109","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N Engl J Med. 2019;380(24):2307\u201316.","journal-title":"N Engl J Med"},{"issue":"1","key":"4551_CR110","doi-asserted-by":"publisher","first-page":"31022","DOI":"10.1038\/srep31022","volume":"6","author":"Y Pan","year":"2016","unstructured":"Pan Y, Daito T, Sasaki Y, Chung YH, Xing X, Pondugula S, et al. Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity. Sci Rep. 2016;6(1):31022.","journal-title":"Sci Rep"},{"key":"4551_CR111","doi-asserted-by":"crossref","unstructured":"Kappos L, Radue E-W, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 2010;362(5):387-401.10.1056\/nejmoa0909494.","DOI":"10.1056\/NEJMoa0909494"},{"key":"4551_CR112","doi-asserted-by":"publisher","unstructured":"Consortium*\u2020 IMSG, Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188doi. https:\/\/doi.org\/10.1126\/science.aav7188.","DOI":"10.1126\/science.aav7188"},{"issue":"6578","key":"4551_CR113","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222.","journal-title":"Science"},{"key":"4551_CR114","doi-asserted-by":"crossref","unstructured":"Kaya Z, Belder N, Sever-Bahcekapili M, Erdener \u015eE, D\u00f6nmez-Demir B, Ba\u011fc\u0131 C et al. Spreading depolarization triggers pro- and anti-inflammatory signalling: a potential link to headache. Brain. 2025;148(7):2522\u2009\u2013\u200936.10.1093\/brain\/awaf015.","DOI":"10.1093\/brain\/awaf015"},{"key":"4551_CR115","doi-asserted-by":"crossref","unstructured":"Goadsby PJ, Wietecha LA, Dennehy EB, Kuca B, Case MG, Aurora SK et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain. 2019;142(7):1894\u2009\u2013\u2009904.10.1093\/brain\/awz134.","DOI":"10.1093\/brain\/awz134"},{"issue":"23","key":"4551_CR116","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","volume":"381","author":"DW Dodick","year":"2019","unstructured":"Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, et al. Ubrogepant for the treatment of migraine. N Engl J Med. 2019;381(23):2230\u201341.","journal-title":"N Engl J Med"},{"issue":"22","key":"4551_CR117","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa1705848","volume":"377","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Reuter U, Hallstr\u00f6m Y, Broessner G, Bonner JH, Zhang F, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017;377(22):2123\u201332.","journal-title":"N Engl J Med"},{"issue":"16","key":"4551_CR118","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington\u2019s Disease Research. Int J Mol Sci [Internet]. 2023;24(16):13021.","journal-title":"Int J Mol Sci [Internet]"},{"key":"4551_CR119","doi-asserted-by":"crossref","unstructured":"Eshraghi M, Karunadharma PP, Blin J, Shahani N, Ricci EP, Michel A et al. Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease. Nature Communications. 2021;12(1):1461.10.1038\/s41467-021-21637-y.","DOI":"10.1038\/s41467-021-21637-y"},{"issue":"1","key":"4551_CR120","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JHD-200429","volume":"10","author":"DG Monckton","year":"2021","unstructured":"Monckton DG. The contribution of somatic expansion of the CAG repeat to symptomatic development in Huntington\u2019s disease: A historical perspective. J Huntington\u2019s Disease. 2021;10(1):7\u201333.","journal-title":"J Huntington\u2019s Disease"},{"key":"4551_CR121","doi-asserted-by":"publisher","first-page":"1401706","DOI":"10.3389\/fnins.2024.1401706","volume":"18","author":"D Bradford","year":"2024","unstructured":"Bradford D, Rodgers KE. Advancements and challenges in amyotrophic lateral sclerosis. Front NeuroSci. 2024;18:1401706.","journal-title":"Front NeuroSci"},{"key":"4551_CR122","doi-asserted-by":"crossref","unstructured":"Ovsepian SV, O\u2019Leary VB, Martinez S. Selective vulnerability of motor neuron types and functional groups to degeneration in amyotrophic lateral sclerosis: review of the neurobiological mechanisms and functional correlates. Brain Structure and Function. 2024;229(1):1-14.10.1007\/s00429-023-02728-6.","DOI":"10.1007\/s00429-023-02728-6"},{"key":"4551_CR123","doi-asserted-by":"publisher","unstructured":"Podbielska M, Banik NL, Kurowska E, Hogan EL. Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci. 2013;3(3):1282-324. https:\/\/doi.org\/10.3390\/brainsci3031282.","DOI":"10.3390\/brainsci3031282"},{"issue":"9","key":"4551_CR124","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3390\/biomedicines11092489","volume":"11","author":"L Eva","year":"2023","unstructured":"Eva L, Ple\u0219 H, Covache-Busuioc R-A, Glavan LA, Bratu B-G, Bordeianu A, et al. A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. Biomedicines [Internet]. 2023;11(9):2489.","journal-title":"Biomedicines [Internet]"},{"key":"4551_CR125","doi-asserted-by":"crossref","unstructured":"Shariff S, Nouh HA, Inshutiyimana S, Kachouh C, Abdelwahab MM, Nazir A et al. Advances in understanding the pathogenesis of epilepsy: Unraveling the molecular mechanisms: A cross-sectional study. Health Sci Rep. 2024;7(2):e1896.10.1002\/hsr2.1896.","DOI":"10.1002\/hsr2.1896"},{"key":"4551_CR126","doi-asserted-by":"crossref","unstructured":"Sumadewi KT, Harkitasari S, Tjandra DC. Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptologica. 2023;5(1):28.10.1186\/s42494-023-00137-0.","DOI":"10.1186\/s42494-023-00137-0"},{"issue":"1","key":"4551_CR127","doi-asserted-by":"publisher","first-page":"e200240","DOI":"10.1212\/NXG.0000000000200240","volume":"11","author":"Y Zhan","year":"2025","unstructured":"Zhan Y, Chen S, Jin Z, Zhou J, Zhang Y-X, Hou Q, et al. Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia and Epilepsy. Neurol Genet. 2025;11(1):e200240. https:\/\/doi.org\/10.1212\/NXG.0000000000200240.","journal-title":"Neurol Genet"},{"key":"4551_CR128","doi-asserted-by":"crossref","unstructured":"Schaper FLWVJ, Nordberg J, Cohen AL, Lin C, Hsu J, Horn A et al. Mapping Lesion-Related Epilepsy to a Human Brain Network. JAMA Neurology. 2023;80(9):891-902.10.1001\/jamaneurol.2023.1988.","DOI":"10.1001\/jamaneurol.2023.1988"},{"key":"4551_CR129","doi-asserted-by":"crossref","unstructured":"Seidel S, Wehner T, Miller D, Wellmer J, Schlegel U, Gr\u00f6nheit W. Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication. Neurol Res Pract. 2022;4(1):45.10.1186\/s42466-022-00205-9.","DOI":"10.1186\/s42466-022-00205-9"},{"key":"4551_CR130","doi-asserted-by":"crossref","unstructured":"Lucke-Wold BP, Nguyen L, Turner RC, Logsdon AF, Chen Y-W, Smith KE et al. Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure. Seizure - European Journal of Epilepsy. 2015;33:13-23.10.1016\/j.seizure.2015.10.002.","DOI":"10.1016\/j.seizure.2015.10.002"},{"key":"4551_CR131","doi-asserted-by":"crossref","unstructured":"Toda T. Genetics of neurological and psychiatric disorders. Journal of Human Genetics. 2023;68(3):113-.10.1038\/s10038-022-01114-0.","DOI":"10.1038\/s10038-022-01114-0"},{"key":"4551_CR132","doi-asserted-by":"crossref","unstructured":"Johnson-Black PH, Carlson JM, Vespa PM. Chapter 6 - Traumatic brain injury and disorders of consciousness. In: Kaplan PW, Geocadin RG, editors. Handbook of Clinical Neurology. Volume 207. Elsevier; 2025. pp. 75\u201396.","DOI":"10.1016\/B978-0-443-13408-1.00014-2"},{"key":"4551_CR133","doi-asserted-by":"crossref","unstructured":"Tshala-Katumbay D, Mwanza J-C, Rohlman DS, Maestre G, Ori\u00e1 RB. A global perspective on the influence of environmental exposures on the nervous system. Nature. 2015;527(7578):S187-S92.10.1038\/nature16034.","DOI":"10.1038\/nature16034"},{"key":"4551_CR134","doi-asserted-by":"crossref","unstructured":"Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci. 2011;124(2):225\u2009\u2013\u200950.10.1093\/toxsci\/kfr239.","DOI":"10.1093\/toxsci\/kfr239"},{"issue":"5","key":"4551_CR135","doi-asserted-by":"publisher","first-page":"e213347","DOI":"10.1212\/WNL.0000000000213347","volume":"104","author":"A-L Turpin","year":"2025","unstructured":"Turpin A-L, Felisatti F, Chauveau L, Haudry S, M\u00e9zenge F, Landeau B, et al. Association Between Lifestyle at Different Life Periods and Brain Integrity in Older Adults. Neurology. 2025;104(5):e213347. https:\/\/doi.org\/10.1212\/WNL.0000000000213347.","journal-title":"Neurology"},{"key":"4551_CR136","doi-asserted-by":"publisher","first-page":"1006106","DOI":"10.37349\/en.2025.1006106","volume":"4","author":"DM Hermann","year":"2025","unstructured":"Hermann DM, Bacigaluppi M, Bassetti CL, Bassotti G, Boltze J, Chan A, et al. Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation. Explor Neurosci. 2025;4:1006106.","journal-title":"Explor Neurosci"},{"key":"4551_CR137","unstructured":"Suchowersky O, Hurtig H, Eichler A. Huntington disease: Clinical features and diagnosis. UpToDate. 2014."},{"issue":"8","key":"4551_CR138","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK. Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91(8):795\u2013808.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4551_CR139","doi-asserted-by":"crossref","unstructured":"Tenchov R, Sasso JM, Zhou QA. Alzheimer\u2019s Disease: Exploring the Landscape of Cognitive Decline. ACS Chem Neurosci. 2024;15(21):3800\u2009\u2013\u200927.10.1021\/acschemneuro.4c00339.","DOI":"10.1021\/acschemneuro.4c00339"},{"key":"4551_CR140","doi-asserted-by":"crossref","unstructured":"Andersson J, Rejn\u00f6 \u00c5, Jakobsson S, Hansson PO, Nielsen SJ, Bj\u00f6rck L. Symptoms at stroke onset as described by patients: a qualitative study. BMC Neurol. 2024;24(1):150.10.1186\/s12883-024-03658-4.","DOI":"10.1186\/s12883-024-03658-4"},{"key":"4551_CR141","doi-asserted-by":"crossref","unstructured":"Anwar H, Khan QU, Nadeem N, Pervaiz I, Ali M, Cheema FF. Epileptic seizures. Discoveries (Craiova). 2020;8(2):e110.10.15190\/d.2020.7.","DOI":"10.15190\/d.2020.7"},{"key":"4551_CR142","doi-asserted-by":"crossref","unstructured":"Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R et al. Donepezil and Memantine for Moderate-to-Severe Alzheimer\u2019s Disease. New England Journal of Medicine.366(10):893-903.10.1056\/NEJMoa1106668.","DOI":"10.1056\/NEJMoa1106668"},{"key":"4551_CR143","doi-asserted-by":"crossref","unstructured":"Tang BC, Wang YT, Ren J. Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications. Ibrain. 2023;9(3):340\u2009\u2013\u20098.10.1002\/ibra.12098.","DOI":"10.1002\/ibra.12098"},{"issue":"Supplement 1","key":"4551_CR144","first-page":"7710393260","volume":"77","author":"L Metzger","year":"2023","unstructured":"Metzger L, Henley L, Smallfield S, Green M, Rhodus EK. Interventions within the scope of occupational therapy to improve cognitive performance for individuals with dementia and mild cognitive impairment (2018\u20132022). Am J Occup Therapy. 2023;77(Supplement 1):7710393260.","journal-title":"Am J Occup Therapy"},{"issue":"7","key":"4551_CR145","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, et al. Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals. Mov Disord. 2023;38(7):1236\u201352.","journal-title":"Mov Disord"},{"issue":"1","key":"4551_CR146","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1212\/CPJ.0000000000000316","volume":"7","author":"AJ Espay","year":"2017","unstructured":"Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, et al. Optimizing extended-release carbidopa\/levodopa in Parkinson disease. Neurol Clin Pract. 2017;7(1):86\u201393. https:\/\/doi.org\/10.1212\/CPJ.0000000000000316.","journal-title":"Neurol Clin Pract"},{"key":"4551_CR147","doi-asserted-by":"crossref","unstructured":"Tan YY, Jenner P, Chen SD. Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson\u2019s Disease: Past, Present, and Future. J Parkinsons Dis. 2022;12(2):477\u2009\u2013\u200993.10.3233\/jpd-212976.","DOI":"10.3233\/JPD-212976"},{"issue":"2","key":"4551_CR148","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nrl.2023.04.002","volume":"40","author":"D Santos Garc\u00eda","year":"2025","unstructured":"Santos Garc\u00eda D, Pagonabarraga Mora J, Escamilla Sevilla F, Garc\u00eda Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, et al. Dopamine agonist therapy in Parkinson\u2019s disease: Spanish expert consensus on its use in different clinical situations. Neurolog\u00eda. 2025;40(2):171\u201381. https:\/\/doi.org\/10.1016\/j.nrl.2023.04.002.","journal-title":"Neurolog\u00eda"},{"issue":"1","key":"4551_CR149","doi-asserted-by":"publisher","first-page":"85","DOI":"10.22543\/2392-7674.1365","volume":"10","author":"B Sohail","year":"2023","unstructured":"Sohail B, Iqbal MA, Razzaq A, Nafe AW, Malik R. Recent Advances in the Role of Rehabilitative Therapies for Parkinson\u2019s Disease: A Literature Review. J Mind Med Sci [Internet]. 2023;10(1):85\u2013105. pp.].","journal-title":"J Mind Med Sci [Internet]"},{"key":"4551_CR150","doi-asserted-by":"crossref","unstructured":"O\u2019Neill R, Yoo O, Burcham P, Lim LY. Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile. Pharmaceutics. 2024;16(8).10.3390\/pharmaceutics16080993.","DOI":"10.3390\/pharmaceutics16080993"},{"key":"4551_CR151","doi-asserted-by":"crossref","unstructured":"Fang T, Al Khleifat A, Meurgey JH, Jones A, Leigh PN, Bensimon G et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17(5):416\u2009\u2013\u200922.10.1016\/s1474-4422(18)30054-1.","DOI":"10.1016\/S1474-4422(18)30054-1"},{"key":"4551_CR152","doi-asserted-by":"crossref","unstructured":"Jackson CE, McVey AL, Rudnicki S, Dimachkie MM, Barohn RJ. Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis. Neurol Clin. 2015;33(4):889-908.10.1016\/j.ncl.2015.07.010.","DOI":"10.1016\/j.ncl.2015.07.010"},{"key":"4551_CR153","doi-asserted-by":"publisher","first-page":"1637577","DOI":"10.3389\/fphar.2025.1637577","volume":"16","author":"J Huang","year":"2025","unstructured":"Huang J, Chen F-F, Wen S-Y, Tao P, Meng C, Chen W, et al. Efficacy and safety of vesicular monoamine transporter 2 inhibitors for Huntington\u2019s disease chorea based on network meta-analysis. Front Pharmacol. 2025;16:1637577.","journal-title":"Front Pharmacol"},{"key":"4551_CR154","doi-asserted-by":"crossref","unstructured":"DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ. 2016;47:20-33.10.1016\/j.jhealeco.2016.01.012.","DOI":"10.1016\/j.jhealeco.2016.01.012"},{"key":"4551_CR155","doi-asserted-by":"crossref","unstructured":"Strittmatter SM. Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks. Nat Med. 2014;20(6):590\u2009\u2013\u20091.10.1038\/nm.3595.","DOI":"10.1038\/nm.3595"},{"key":"4551_CR156","doi-asserted-by":"publisher","unstructured":"Mao X-Y. Drug Repurposing in Neurological Diseases: Opportunities and Challenges [Internet]. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications. IntechOpen; 2020. https:\/\/doi.org\/10.5772\/intechopen.93093.","DOI":"10.5772\/intechopen.93093"},{"key":"4551_CR157","doi-asserted-by":"crossref","unstructured":"Danysz W, Hansen N, Wiltfang J, Kornhuber J, Scheschonka A, Gravius A. Memantine: updates from the past decade and implications for future novel therapeutic applications. Journal of Neural Transmission. 2025.10.1007\/s00702-025-03017-8.","DOI":"10.1007\/s00702-025-03017-8"},{"key":"4551_CR158","doi-asserted-by":"publisher","first-page":"107872","DOI":"10.1016\/j.parkreldis.2025.107872","volume":"139","author":"M Auffret","year":"2025","unstructured":"Auffret M. Apomorphine: past, present and future in Parkinson\u2019s disease and beyond. Parkinsonism Relat Disord. 2025;139:107872. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107872.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"4551_CR159","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(21)00249-0","volume":"20","author":"O Rascol","year":"2021","unstructured":"Rascol O, Fabbri M, Poewe W. Amantadine in the treatment of Parkinson\u2019s disease and other movement disorders. Lancet Neurol. 2021;20(12):1048\u201356. https:\/\/doi.org\/10.1016\/S1474-4422(21)00249-0.","journal-title":"Lancet Neurol"},{"key":"4551_CR160","doi-asserted-by":"crossref","unstructured":"Romoli M, Mazzocchetti P, D\u2019Alonzo R, Siliquini S, Rinaldi VE, Verrotti A et al. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences. Curr Neuropharmacol. 2019;17(10):926\u2009\u2013\u200946.10.2174\/1570159x17666181227165722.","DOI":"10.2174\/1570159X17666181227165722"},{"key":"4551_CR161","doi-asserted-by":"crossref","unstructured":"Linde K, Rossnagel K. WITHDRAWN: Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2017;2(2):Cd003225.10.1002\/14651858.CD003225.pub3.","DOI":"10.1002\/14651858.CD003225.pub3"},{"key":"4551_CR162","doi-asserted-by":"publisher","first-page":"123132","DOI":"10.1016\/j.jns.2024.123132","volume":"463","author":"V Nikitina","year":"2024","unstructured":"Nikitina V, Santi Laurini G, Montanaro N, Motola D. Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database. J Neurol Sci. 2024;463:123132. https:\/\/doi.org\/10.1016\/j.jns.2024.123132.","journal-title":"J Neurol Sci"},{"key":"4551_CR163","doi-asserted-by":"publisher","first-page":"915362","DOI":"10.3389\/fneur.2022.915362","volume":"13","author":"E Premi","year":"2022","unstructured":"Premi E, Cantoni V, Benussi A, Gilberti N, Vergani V, Delrio I, et al. Citicoline treatment in acute ischemic stroke: A randomized, single-blind TMS study. Front Neurol. 2022;13:915362.","journal-title":"Front Neurol"},{"issue":"1\u20132","key":"4551_CR164","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/21678421.2024.2375330","volume":"26","author":"P Corcia","year":"2025","unstructured":"Corcia P, Guy N, Pradat P-F, Soriani M-H, Verschueren A, Couratier P. Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: State of the art and current challenges in a \u2018real-world\u2019setting. Amyotroph Lateral Scler Frontotemporal Degeneration. 2025;26(1\u20132):15\u201321.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"issue":"3","key":"4551_CR165","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ipha.2024.02.009","volume":"2","author":"S Yadav","year":"2024","unstructured":"Yadav S, Singh A, Singhal R, Yadav JP. Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry. Intell Pharm. 2024;2(3):367\u201380. https:\/\/doi.org\/10.1016\/j.ipha.2024.02.009.","journal-title":"Intell Pharm"},{"key":"4551_CR166","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduction and Targeted Therapy. 2024;9(1):211.10.1038\/s41392-024-01911-3.","DOI":"10.1038\/s41392-024-01911-3"},{"key":"4551_CR167","doi-asserted-by":"crossref","unstructured":"Ranson JM, Bucholc M, Lyall D, Newby D, Winchester L, Oxtoby NP et al. Harnessing the potential of machine learning and artificial intelligence for dementia research. Brain Informatics. 2023;10(1):6.10.1186\/s40708-022-00183-3.","DOI":"10.1186\/s40708-022-00183-3"},{"issue":"8","key":"4551_CR168","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.jpha.2025.101248","volume":"15","author":"C Fu","year":"2025","unstructured":"Fu C, Chen Q. The future of pharmaceuticals: Artificial intelligence in drug discovery and development. J Pharm Anal. 2025;15(8):101248. https:\/\/doi.org\/10.1016\/j.jpha.2025.101248.","journal-title":"J Pharm Anal"},{"key":"4551_CR169","doi-asserted-by":"crossref","unstructured":"Rajaei F, Minoccheri C, Wittrup E, Wilson RC, Athey BD, Omenn GS et al. AI-Based Computational Methods in Early Drug Discovery and Post Market Drug Assessment: A Survey. IEEE Trans Comput Biol Bioinform. 2025;22(1):97-115.10.1109\/tcbb.2024.3492708.","DOI":"10.1109\/TCBB.2024.3492708"},{"key":"4551_CR170","doi-asserted-by":"crossref","unstructured":"Pathak A, Theagarajan R, Rizqi MM, Nugraha AS, Boruah T, Pratiksha et al. AI-enabled drug and molecular discovery: computational methods, platforms, and translational horizons. Discover Molecules. 2025;2(1):32.10.1007\/s44345-025-00037-5.","DOI":"10.1007\/s44345-025-00037-5"},{"key":"4551_CR171","doi-asserted-by":"crossref","unstructured":"Gao L, Wang J, Bi Y. Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics. Int J Nanomedicine. 2025;20:11015\u2009\u2013\u200944.10.2147\/ijn.S549893.","DOI":"10.2147\/IJN.S549893"},{"key":"4551_CR172","doi-asserted-by":"crossref","unstructured":"Cho S, Rasoulianboroujeni M, Kang RH, Kwon GS. From Conventional to Next-Generation Strategies: Recent Advances in Polymeric Micelle Preparation for Drug Delivery. Pharmaceutics. 2025;17(10).10.3390\/pharmaceutics17101360.","DOI":"10.3390\/pharmaceutics17101360"},{"key":"4551_CR173","doi-asserted-by":"crossref","unstructured":"Zhang P, Hu L, Yin Q, Feng L, Li Y. Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy. Mol Pharm. 2012;9(6):1590\u2009\u2013\u20098.10.1021\/mp200600t.","DOI":"10.1021\/mp200600t"},{"issue":"23","key":"4551_CR174","doi-asserted-by":"publisher","first-page":"14667","DOI":"10.3390\/ijms232314667","volume":"23","author":"AB Chai","year":"2022","unstructured":"Chai AB, Callaghan R, Gelissen IC. Regulation of P-Glycoprotein in the Brain. Int J Mol Sci [Internet]. 2022;23(23):14667.","journal-title":"Int J Mol Sci [Internet]"},{"key":"4551_CR175","doi-asserted-by":"crossref","unstructured":"Attri N, Das S, Banerjee J, Shamsuddin SH, Dash SK, Pramanik A. Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications. ACS Appl Bio Mater. 2024;7(5):2677\u2009\u2013\u200994.10.1021\/acsabm.4c00153.","DOI":"10.1021\/acsabm.4c00153"},{"key":"4551_CR176","doi-asserted-by":"crossref","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117\u2009\u2013\u200934.10.1016\/j.jconrel.2012.03.020.","DOI":"10.1016\/j.jconrel.2012.03.020"},{"key":"4551_CR177","doi-asserted-by":"publisher","first-page":"106725","DOI":"10.1016\/j.jddst.2025.106725","volume":"106","author":"H Chen","year":"2025","unstructured":"Chen H, Wu L, Chen H, Wu W, Zhang Q. Influence of polyethylene glycol coating of different molecular weights and densities on liposome properties. J Drug Deliv Sci Technol. 2025;106:106725. https:\/\/doi.org\/10.1016\/j.jddst.2025.106725.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4551_CR178","doi-asserted-by":"crossref","unstructured":"Juhairiyah F, de Lange ECM. Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential. Aaps j. 2021;23(6):114.10.1208\/s12248-021-00648-z.","DOI":"10.1208\/s12248-021-00648-z"},{"key":"4551_CR179","doi-asserted-by":"crossref","unstructured":"Zou Z, Jiang X, Zhang W, Zhou Y, Ke Y, Zhang S et al. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson\u2019s disease\u2013a rat model study. Brain Res. 2010;1346:279\u2009\u2013\u200986.10.1016\/j.brainres.2010.05.071.","DOI":"10.1016\/j.brainres.2010.05.071"},{"key":"4551_CR180","doi-asserted-by":"crossref","unstructured":"Zong T, Mei L, Gao H, Cai W, Zhu P, Shi K et al. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Mol Pharm. 2014;11(7):2346\u2009\u2013\u200957.10.1021\/mp500057n.","DOI":"10.1021\/mp500057n"},{"key":"4551_CR181","doi-asserted-by":"crossref","unstructured":"Gressler S, Hipfinger C, Part F, Pavlicek A, Zafiu C, Giese B. A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework. J Nanobiotechnology. 2025;23(1):90.10.1186\/s12951-025-03113-7.","DOI":"10.1186\/s12951-025-03113-7"},{"key":"4551_CR182","doi-asserted-by":"crossref","unstructured":"Chis AA, Dobrea C, Morgovan C, Arseniu AM, Rus LL, Butuca A et al. Applications and Limitations of Dendrimers in Biomedicine. Molecules. 2020;25(17).10.3390\/molecules25173982.","DOI":"10.3390\/molecules25173982"},{"key":"4551_CR183","doi-asserted-by":"crossref","unstructured":"Preeti SS, Malik R, Bhatia S, Al Harrasi A, Rani C et al. Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Scientifica (Cairo). 2023;2023:6640103.10.1155\/2023\/6640103.","DOI":"10.1155\/2023\/6640103"},{"key":"4551_CR184","doi-asserted-by":"crossref","unstructured":"Shah L, Yadav S, Amiji M. Nanotechnology for CNS delivery of bio-therapeutic agents. Drug Deliv Transl Res. 2013;3(4):336\u2009\u2013\u200951.10.1007\/s13346-013-0133-3.","DOI":"10.1007\/s13346-013-0133-3"},{"key":"4551_CR185","doi-asserted-by":"crossref","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: Structure, regulation and drug delivery. Signal Transduction and Targeted Therapy. 2023;8(1):217.10.1038\/s41392-023-01481-w.","DOI":"10.1038\/s41392-023-01481-w"},{"key":"4551_CR186","doi-asserted-by":"crossref","unstructured":"Li X, Peng X, Zoulikha M, Boafo GF, Magar KT, Ju Y et al. Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal Transduction and Targeted Therapy. 2024;9(1):1.10.1038\/s41392-023-01668-1.","DOI":"10.1038\/s41392-023-01668-1"},{"key":"4551_CR187","doi-asserted-by":"crossref","unstructured":"Fu C, Chen Q. The future of pharmaceuticals: Artificial intelligence in drug discovery and development. J Pharm Anal. 2025;15(8):101248.10.1016\/j.jpha.2025.101248.","DOI":"10.1016\/j.jpha.2025.101248"},{"key":"4551_CR188","doi-asserted-by":"publisher","unstructured":"Vidhya KS, Sultana A, M NK, Rangareddy H. Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside. Cureus. 2023;15(10):e47486. https:\/\/doi.org\/10.7759\/cureus.47486","DOI":"10.7759\/cureus.47486"},{"key":"4551_CR189","doi-asserted-by":"publisher","unstructured":"Okafor NI, Igbokwe N, Onohuean H, Faya M, Choonara YE. Artificial Intelligence-Driven Development and Characterization of Nanomedicine. BioNanoScience. 2026;16(4):255. https:\/\/doi.org\/10.1007\/s12668-026-02476-x.","DOI":"10.1007\/s12668-026-02476-x"},{"issue":"1","key":"4551_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ipha.2025.08.001","volume":"4","author":"D Sridhar","year":"2026","unstructured":"Sridhar D, Manikandan R, Dhanapal Y, Khute S, Subash P. Artificial intelligence in predicting personalized nanocarrier formulations for herbal drugs: Bridging phytomedicine and precision nanotechnology. Intell Pharm. 2026;4(1):1\u201311. https:\/\/doi.org\/10.1016\/j.ipha.2025.08.001.","journal-title":"Intell Pharm"},{"key":"4551_CR191","doi-asserted-by":"crossref","unstructured":"Aliper A, Plis S, Artemov A, Ulloa A, Mamoshina P, Zhavoronkov A. Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data. Molecular Pharmaceutics. 2016;13(7):2524\u2009\u2013\u200930.10.1021\/acs.molpharmaceut.6b00248.","DOI":"10.1021\/acs.molpharmaceut.6b00248"},{"issue":"3","key":"4551_CR192","doi-asserted-by":"publisher","first-page":"e70002","DOI":"10.1002\/qub2.70002","volume":"13","author":"A Yetgin","year":"2025","unstructured":"Yetgin A. Revolutionizing multi-omics analysis with artificial intelligence and data processing. Quant Biology. 2025;13(3):e70002.","journal-title":"Quant Biology"},{"key":"4551_CR193","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S et al. The Genotype-Tissue Expression (GTEx) project. Nature Genetics. 2013;45(6):580\u2009\u2013\u20095.10.1038\/ng.2653."},{"key":"4551_CR194","doi-asserted-by":"crossref","unstructured":"Tam V, Patel N, Turcotte M, Boss\u00e9 Y, Par\u00e9 G, Meyre D. Benefits and limitations of genome-wide association studies. Nature Reviews Genetics. 2019;20(8):467\u2009\u2013\u200984.10.1038\/s41576-019-0127-1.","DOI":"10.1038\/s41576-019-0127-1"},{"key":"4551_CR195","doi-asserted-by":"crossref","unstructured":"Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biology. 2017;18(1):83.10.1186\/s13059-017-1215-1.","DOI":"10.1186\/s13059-017-1215-1"},{"key":"4551_CR196","doi-asserted-by":"crossref","unstructured":"Wang M, Song W-m, Ming C, Wang Q, Zhou X, Xu P et al. Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer\u2019s disease: review, recommendation, implementation and application. Molecular Neurodegeneration. 2022;17(1):17.10.1186\/s13024-022-00517-z.","DOI":"10.1186\/s13024-022-00517-z"},{"key":"4551_CR197","doi-asserted-by":"crossref","unstructured":"Hong EL, Sloan CA, Chan ET, Davidson JM, Malladi VS, Strattan JS et al. Principles of metadata organization at the ENCODE data coordination center. Database. 2016;2016.10.1093\/database\/baw001.","DOI":"10.1093\/database\/baw001"},{"key":"4551_CR198","doi-asserted-by":"crossref","unstructured":"Luo Y, Hitz BC, Gabdank I, Hilton JA, Kagda MS, Lam B et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Research. 2019;48(D1):D882-D9.10.1093\/nar\/gkz1062.","DOI":"10.1093\/nar\/gkz1062"},{"key":"4551_CR199","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume-title":"Statistical Genomics: Methods and Protocols","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T. The Gene Expression Omnibus Database. In: Math\u00e9 E, Davis S, editors. Statistical Genomics: Methods and Protocols. New York, NY: Springer New York; 2016. pp. 93\u2013110."},{"key":"4551_CR200","doi-asserted-by":"crossref","unstructured":"Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Research. 2023;52(D1):D1180-D92.10.1093\/nar\/gkad1004.","DOI":"10.1093\/nar\/gkad1004"},{"key":"4551_CR201","doi-asserted-by":"crossref","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Research. 2020;49(D1):D1388-D95.10.1093\/nar\/gkaa971.","DOI":"10.1093\/nar\/gkaa971"},{"issue":"11","key":"4551_CR202","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1080\/17460441.2025.2558161","volume":"20","author":"A Marb\u00e1n-Gonz\u00e1lez","year":"2025","unstructured":"Marb\u00e1n-Gonz\u00e1lez A, Ram\u00edrez-Cid V, Crist\u00f3bal-Ram\u00edrez A, Medina-Franco JL. Exploiting PubChem and other public databases for virtual screening in 2025: what are the latest trends? Expert Opin Drug Discov. 2025;20(11):1387\u2013403.","journal-title":"Expert Opin Drug Discov"},{"key":"4551_CR203","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Research. 2022;51(D1):D587-D92.10.1093\/nar\/gkac963.","DOI":"10.1093\/nar\/gkac963"},{"issue":"5","key":"4551_CR204","doi-asserted-by":"publisher","first-page":"405","DOI":"10.26502\/fccm.92920400","volume":"8","author":"I Batta","year":"2024","unstructured":"Batta I, Patial R, Sobti RC, Agrawal DK. Computational Biology in the Discovery of Biomarkers in the Diagnosis, Treatment and Management of Cardiovascular Diseases. Cardiol Cardiovasc Med. 2024;8(5):405\u201314.","journal-title":"Cardiol Cardiovasc Med"},{"issue":"1","key":"4551_CR205","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.neumar.2024.100034","volume":"2","author":"AT Aborode","year":"2025","unstructured":"Aborode AT, Emmanuel OA, Onifade IA, Olotu E, Otorkpa OJ, Mehmood Q, et al. The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review. NeuroMarkers. 2025;2(1):100034. https:\/\/doi.org\/10.1016\/j.neumar.2024.100034.","journal-title":"NeuroMarkers"},{"issue":"12","key":"4551_CR206","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3390\/diagnostics11122303","volume":"11","author":"L Madrid","year":"2021","unstructured":"Madrid L, Labrador SC, Gonz\u00e1lez-P\u00e9rez A, S\u00e1ez ME. The Alzheimer\u2019s Disease Neuroimaging I. Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer\u2019s Disease. Diagnostics [Internet]. 2021;11(12):2303.","journal-title":"Diagnostics [Internet]"},{"issue":"9","key":"4551_CR207","doi-asserted-by":"publisher","first-page":"e0254326","DOI":"10.1371\/journal.pone.0254326","volume":"16","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Huang D, Zhao Z, Lu C. Bioinformatic analysis identifies potential key genes of epilepsy. PLoS ONE. 2021;16(9):e0254326.","journal-title":"PLoS ONE"},{"key":"4551_CR208","doi-asserted-by":"crossref","unstructured":"Salapa HE, Thibault PA, Libner CD, Ding Y, Clarke J-PWE, Denomy C et al. hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS). Nature Communications. 2024;15(1):356.10.1038\/s41467-023-44658-1.","DOI":"10.1038\/s41467-023-44658-1"},{"key":"4551_CR209","doi-asserted-by":"crossref","unstructured":"Chen R, Liu J, Li S, Li X, Huo Y, Yao Y-G et al. Functional genomics elucidates regulatory mechanisms of Parkinson\u2019s disease-associated variants. BMC Medicine. 2022;20(1):68.10.1186\/s12916-022-02264-w.","DOI":"10.1186\/s12916-022-02264-w"},{"key":"4551_CR210","doi-asserted-by":"publisher","first-page":"1061860","DOI":"10.3389\/fneur.2023.1061860","volume":"14","author":"H Gao","year":"2023","unstructured":"Gao H, Li J, Li Q, Lin Y. Identification of hub genes significantly linked to subarachnoid hemorrhage and epilepsy via bioinformatics analysis. Front Neurol. 2023;14:1061860.","journal-title":"Front Neurol"},{"issue":"1","key":"4551_CR211","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-publhealth-040218-044206","volume":"40","author":"H Atasoy","year":"2019","unstructured":"Atasoy H, Greenwood BN, McCullough JS. The digitization of patient care: a review of the effects of electronic health records on health care quality and utilization. Annu Rev Public Health. 2019;40(1):487\u2013500.","journal-title":"Annu Rev Public Health"},{"key":"4551_CR212","doi-asserted-by":"crossref","unstructured":"Li VOK, Han Y, Kaistha T, Zhang Q, Downey J, Gozes I et al. DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer\u2019s disease. Scientific Reports. 2025;15(1):2093.10.1038\/s41598-025-85947-7.","DOI":"10.1038\/s41598-025-85947-7"},{"key":"4551_CR213","doi-asserted-by":"crossref","unstructured":"McCoach CE, Berge EM, Lu X, Bar\u00f3n AE, Camidge DR. A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non\u2013Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry. Journal of Thoracic Oncology. 2016;11(3):407\u2009\u2013\u200913.10.1016\/j.jtho.2015.10.024.","DOI":"10.1016\/j.jtho.2015.10.024"},{"key":"4551_CR214","doi-asserted-by":"publisher","first-page":"1228148","DOI":"10.3389\/fphar.2023.1228148","volume":"14","author":"ED Namiot","year":"2023","unstructured":"Namiot ED, Smirnovov\u00e1 D, Sokolov AV, Chubarev VN, Tarasov VV, Schi\u00f6th HB. The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs. Front Pharmacol. 2023;14:1228148.","journal-title":"Front Pharmacol"},{"key":"4551_CR215","doi-asserted-by":"crossref","unstructured":"Manzoni C, Kia DA, Vandrovcova J, Hardy J, Wood NW, Lewis PA et al. Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform. 2018;19(2):286-302.10.1093\/bib\/bbw114.","DOI":"10.1093\/bib\/bbw114"},{"key":"4551_CR216","doi-asserted-by":"publisher","first-page":"108153","DOI":"10.1016\/j.bspc.2025.108153","volume":"110","author":"A Jovic","year":"2025","unstructured":"Jovic A, Frid N, Brkic K, Cifrek M. Interpretability and accuracy of machine learning algorithms for biomedical time series analysis \u2013 a scoping review. Biomed Signal Process Control. 2025;110:108153. https:\/\/doi.org\/10.1016\/j.bspc.2025.108153.","journal-title":"Biomed Signal Process Control"},{"key":"4551_CR217","doi-asserted-by":"crossref","unstructured":"Coupland H, Scheidwasser N, Katsiferis A, Davies M, Flaxman S, Hulvej Rod N et al. Exploring the potential and limitations of deep learning and explainable AI for longitudinal life course analysis. BMC Public Health. 2025;25(1):1520.10.1186\/s12889-025-22705-4.","DOI":"10.1186\/s12889-025-22705-4"},{"key":"4551_CR218","doi-asserted-by":"crossref","unstructured":"Besharatifard M, Vafaee F. A review on graph neural networks for predicting synergistic drug combinations. Artificial Intelligence Review. 2024;57(3):49.10.1007\/s10462-023-10669-z.","DOI":"10.1007\/s10462-023-10669-z"},{"key":"4551_CR219","doi-asserted-by":"crossref","unstructured":"Sibilio P, De Smaele E, Paci P, Conte F. Integrating multi-omics data: Methods and applications in human complex diseases. Biotechnol Rep (Amst). 2025;48:e00938.10.1016\/j.btre.2025.e00938.","DOI":"10.1016\/j.btre.2025.e00938"},{"key":"4551_CR220","doi-asserted-by":"crossref","unstructured":"Yu H, Fan L, Li L, Zhou J, Ma Z, Xian L et al. Large Language Models in Biomedical and Health Informatics: A Review with Bibliometric Analysis. J Healthc Inform Res. 2024;8(4):658-711.10.1007\/s41666-024-00171-8.","DOI":"10.1007\/s41666-024-00171-8"},{"key":"4551_CR221","unstructured":"He T, Kreimeyer K, Najjar M, Spiker J, Fatteh M, Anagnostou V et al. Artificial Intelligence-assisted Biomedical Literature Knowledge Synthesis to Support Decision-making in Precision Oncology. AMIA Annu Symp Proc. 2024;2024:513\u2009\u2013\u200922."},{"key":"4551_CR222","doi-asserted-by":"crossref","unstructured":"Luo R, Sun L, Xia Y, Qin T, Zhang S, Poon H et al. BioGPT: generative pre-trained transformer for biomedical text generation and mining. Brief Bioinform. 2022;23(6).10.1093\/bib\/bbac409.","DOI":"10.1093\/bib\/bbac409"},{"key":"4551_CR223","doi-asserted-by":"publisher","first-page":"100889","DOI":"10.1016\/j.jik.2025.100889","volume":"12","author":"P Madz\u00edk","year":"2026","unstructured":"Madz\u00edk P, Fal\u00e1t L, Sk\u00fdpalov\u00e1 R, Ja\u0161u\u0161\u00e1kov\u00e1 L, Zimon D. ChatGPT in science and research: How generative AI drives innovation and knowledge development. J Innov Knowl. 2026;12:100889. https:\/\/doi.org\/10.1016\/j.jik.2025.100889.","journal-title":"J Innov Knowl"},{"key":"4551_CR224","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fnins.2015.00307","volume":"9","author":"C Salvatore","year":"2015","unstructured":"Salvatore C, Cerasa A, Battista P, Gilardi MC, Quattrone A, Castiglioni I, et al. Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer\u2019s disease: a machine learning approach. Front NeuroSci. 2015;9:307.","journal-title":"Front NeuroSci"},{"key":"4551_CR225","doi-asserted-by":"crossref","unstructured":"Mottaqi M, Zhang P, Xie L. Integrating explainable artificial intelligence with multiomics systems biology and electronic health record data mining for personalized drug repurposing in Alzheimer\u2019s disease. Briefings in Bioinformatics. 2025;26(6).10.1093\/bib\/bbaf623.","DOI":"10.1093\/bib\/bbaf623"},{"key":"4551_CR226","doi-asserted-by":"crossref","unstructured":"Mishra AK, Jain S. Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer\u2019s Disease. ACS Chemical Neuroscience. 2026;17(2):316\u2009\u2013\u200934.10.1021\/acschemneuro.5c00750.","DOI":"10.1021\/acschemneuro.5c00750"},{"key":"4551_CR227","doi-asserted-by":"crossref","unstructured":"Grabowska ME, Vaidya AU, Zhong X, Guardo C, Dickson AL, Babanejad M et al. Multi-omics analysis reveals aspirin is associated with reduced risk of Alzheimer\u2019s disease. medRxiv. 2025.10.1101\/2025.04.07.25325038.","DOI":"10.1101\/2025.04.07.25325038"},{"key":"4551_CR228","doi-asserted-by":"crossref","unstructured":"Fang J, Zhang P, Zhou Y, Chiang C-W, Tan J, Hou Y et al. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer\u2019s disease. Nature Aging. 2021;1(12):1175\u2009\u2013\u200988.10.1038\/s43587-021-00138-z.","DOI":"10.1038\/s43587-021-00138-z"},{"key":"4551_CR229","doi-asserted-by":"crossref","unstructured":"Wang X, Wang M, Wang H, Yin G, Zhang YD. Drug repurposing for Alzheimer\u2019s disease integrating transcriptome-wide association study and biological network analysis. Journal of Alzheimer\u2019s Disease. 2025;107(1):314\u2009\u2013\u200927.10.1177\/13872877251360009.","DOI":"10.1177\/13872877251360009"},{"key":"4551_CR230","doi-asserted-by":"crossref","unstructured":"Xie S, Liang Y, Song Y, Li T, Jia J. Repurposing Anidulafungin for Alzheimer\u2019s Disease via Fragment-Based Drug Discovery. ACS Chemical Neuroscience. 2024;15(16):2995-3008.10.1021\/acschemneuro.4c00150.","DOI":"10.1021\/acschemneuro.4c00150"},{"issue":"11","key":"4551_CR231","doi-asserted-by":"publisher","first-page":"100274","DOI":"10.1016\/j.mocell.2025.100274","volume":"48","author":"TY Kim","year":"2025","unstructured":"Kim TY, Lee BD. Current therapeutic strategies in Parkinson\u2019s disease: Future perspectives. Mol Cells. 2025;48(11):100274. https:\/\/doi.org\/10.1016\/j.mocell.2025.100274.","journal-title":"Mol Cells"},{"key":"4551_CR232","doi-asserted-by":"crossref","unstructured":"Ricci C. Neurodegenerative Disease: From Molecular Basis to Therapy. Int J Mol Sci. 2024;25(2).10.3390\/ijms25020967.","DOI":"10.3390\/ijms25020967"},{"key":"4551_CR233","doi-asserted-by":"publisher","first-page":"100163","DOI":"10.1016\/j.dscb.2024.100163","volume":"16","author":"D Baggett","year":"2024","unstructured":"Baggett D, Olson A, Parmar MS. Novel approaches targeting \u03b1-Synuclein for Parkinson\u2019s Disease: Current progress and future directions for the disease-modifying therapies. Brain Disorders. 2024;16:100163. https:\/\/doi.org\/10.1016\/j.dscb.2024.100163.","journal-title":"Brain Disorders"},{"key":"4551_CR234","doi-asserted-by":"crossref","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy. 2023;8(1):73.10.1038\/s41392-023-01353-3.","DOI":"10.1038\/s41392-023-01353-3"},{"key":"4551_CR235","doi-asserted-by":"publisher","first-page":"117862","DOI":"10.1016\/j.biopha.2025.117862","volume":"183","author":"M Salvad\u00e8","year":"2025","unstructured":"Salvad\u00e8 M, DiLuca M, Gardoni F. An update on drug repurposing in Parkinson\u2019s disease: Preclinical and clinical considerations. Biomed Pharmacother. 2025;183:117862. https:\/\/doi.org\/10.1016\/j.biopha.2025.117862.","journal-title":"Biomed Pharmacother"},{"key":"4551_CR236","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Parra H, Cort\u00e9s H, Avalos-Fuentes JA, Del Prado-Audelo M, Flor\u00e1n B, Leyva-G\u00f3mez G et al. Repositioning of drugs for Parkinson\u2019s disease and pharmaceutical nanotechnology tools for their optimization. Journal of Nanobiotechnology. 2022;20(1):413.10.1186\/s12951-022-01612-5.","DOI":"10.1186\/s12951-022-01612-5"},{"key":"4551_CR237","doi-asserted-by":"publisher","first-page":"1539032","DOI":"10.3389\/fphar.2025.1539032","volume":"16","author":"X Guo","year":"2025","unstructured":"Guo X, Wang J, Fan H, Tao W, Ren Z, Li X, et al. Computational drug repurposing in Parkinson\u2019s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates. Front Pharmacol. 2025;16:1539032.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4551_CR238","doi-asserted-by":"publisher","first-page":"e0323761","DOI":"10.1371\/journal.pone.0323761","volume":"20","author":"MP Gorenflo","year":"2025","unstructured":"Gorenflo MP, Gao Z, Davis PB, Kaelber D, Xu R. Amphetamine use and Parkinson\u2019s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses. PLoS ONE. 2025;20(5):e0323761.","journal-title":"PLoS ONE"},{"key":"4551_CR239","doi-asserted-by":"publisher","unstructured":"Fletcher EJR, Kaminski T, Williams G, Duty S. Drug repurposing strategies of relevance for Parkinson's disease. Pharmacol Res Perspect. 2021;9(4):e00841. https:\/\/doi.org\/10.1002\/prp2.841.","DOI":"10.1002\/prp2.841"},{"key":"4551_CR240","doi-asserted-by":"publisher","unstructured":"Salvad\u00e8 M, Gardoni F. Drug repurposing of dimethyl fumarate in Parkinson's disease: a promising disease-modifying strategy. Eur Rev Med Pharmacol Sci. 2025;29(9):443-451. https:\/\/doi.org\/10.26355\/eurrev_202509_37406.","DOI":"10.26355\/eurrev_202509_37406"},{"key":"4551_CR241","doi-asserted-by":"crossref","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol Neurodegener. 2023;18(1):83.10.1186\/s13024-023-00676-7.","DOI":"10.1186\/s13024-023-00676-7"},{"key":"4551_CR242","doi-asserted-by":"crossref","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death & Disease. 2023;14(3):176.10.1038\/s41419-023-05672-9.","DOI":"10.1038\/s41419-023-05672-9"},{"key":"4551_CR243","doi-asserted-by":"crossref","unstructured":"Zhou ZD, Yi LX, Wang DQ, Lim TM, Tan EK. Role of dopamine in the pathophysiology of Parkinson\u2019s disease. Transl Neurodegener. 2023;12(1):44.10.1186\/s40035-023-00378-6.","DOI":"10.1186\/s40035-023-00378-6"},{"key":"4551_CR244","doi-asserted-by":"crossref","unstructured":"Wong C, Stavrou M, Elliott E, Gregory JM, Leigh N, Pinto AA et al. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Commun. 2021;3(4):fcab242.10.1093\/braincomms\/fcab242.","DOI":"10.1093\/braincomms\/fcab242"},{"key":"4551_CR245","doi-asserted-by":"crossref","unstructured":"Carroll E, Scaber J, Huber KVM, Brennan PE, Thompson AG, Turner MR et al. Drug repurposing in amyotrophic lateral sclerosis (ALS). Expert Opin Drug Discov. 2025;20(4):447\u2009\u2013\u200964.10.1080\/17460441.2025.2474661.","DOI":"10.1080\/17460441.2025.2474661"},{"key":"4551_CR246","doi-asserted-by":"crossref","unstructured":"Fang T, Je G, Pacut P, Keyhanian K, Gao J, Ghasemi M. Gene Therapy in Amyotrophic Lateral Sclerosis. Cells. 2022;11(13).10.3390\/cells11132066.","DOI":"10.3390\/cells11132066"},{"key":"4551_CR247","doi-asserted-by":"crossref","unstructured":"Dogra S, Kouznetsova VL, Tsigelny IF. Repurposing FDA-approved drugs for treatment of amyotrophic lateral sclerosis using machine learning. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2025:1-9.10.1080\/21678421.2025.2536027.","DOI":"10.1080\/21678421.2025.2536027"},{"key":"4551_CR248","doi-asserted-by":"crossref","unstructured":"Gerring ZF, Bhalala OG, Fearnley LG, Oikari LE, White AR, Derks EM et al. Drug repurposing candidates for amyotrophic lateral sclerosis using common and rare genetic variants. Brain Communications. 2025;7(3).10.1093\/braincomms\/fcaf184.","DOI":"10.1093\/braincomms\/fcaf184"},{"issue":"7","key":"4551_CR249","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/jnnp-2023-332106","volume":"95","author":"R Bowser","year":"2024","unstructured":"Bowser R, An J, Mehta L, Chen J, Timmons J, Cudkowicz M, et al. Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trial. J Neurol Neurosurg Psychiatry. 2024;95(7):605\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4551_CR250","doi-asserted-by":"crossref","unstructured":"Temiz K, Gul A, Gov E. 5-Repurposed Drug Candidates Identified in Motor Neurons and Muscle Tissues with Amyotrophic Lateral Sclerosis by Network Biology and Machine Learning Based on Gene Expression. NeuroMolecular Medicine. 2025;27(1):24.10.1007\/s12017-025-08847-z.","DOI":"10.1007\/s12017-025-08847-z"},{"key":"4551_CR251","doi-asserted-by":"publisher","first-page":"100872","DOI":"10.1016\/j.cophys.2025.100872","volume":"46","author":"S Tanveer","year":"2025","unstructured":"Tanveer S, Bajpai A, Rajput SJ, Saravanan P, Patel BK. Targeting oxidative stress to combat neurodegenerative diseases, amyotrophic lateral sclerosis and Huntington\u2019s, for better brain health and recovery. Curr Opin Physiol. 2025;46:100872. https:\/\/doi.org\/10.1016\/j.cophys.2025.100872.","journal-title":"Curr Opin Physiol"},{"issue":"2","key":"4551_CR252","doi-asserted-by":"publisher","first-page":"693","DOI":"10.14336\/AD.2024.0440","volume":"16","author":"J Xin","year":"2024","unstructured":"Xin J, Huang S, Wen J, Li Y, Li A, Satyanarayanan SK, et al. Drug screening and validation targeting TDP-43 proteinopathy for amyotrophic lateral sclerosis. Aging Disease. 2024;16(2):693.","journal-title":"Aging Disease"},{"key":"4551_CR253","doi-asserted-by":"crossref","unstructured":"Sisignano M, Gribbon P, Geisslinger G. Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain. Drugs. 2022;82(4):357\u2009\u2013\u200973.10.1007\/s40265-022-01689-0.","DOI":"10.1007\/s40265-022-01689-0"},{"key":"4551_CR254","doi-asserted-by":"crossref","unstructured":"Khamaysa M, Pradat PF. Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas. J Pers Med. 2022;12(10).10.3390\/jpm12101601.","DOI":"10.3390\/jpm12101601"},{"key":"4551_CR255","doi-asserted-by":"crossref","unstructured":"G\u00f6ttle P, Dietrich M, K\u00fcry P. Multiple sclerosis drug repurposing for neuroregeneration. Neural Regen Res. 2024;19(3):507\u2009\u2013\u20098.10.4103\/1673-5374.380901.","DOI":"10.4103\/1673-5374.380901"},{"issue":"3","key":"4551_CR256","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/sclerosis3030028","volume":"3","author":"PH Villar-Delfino","year":"2025","unstructured":"Villar-Delfino PH, Pereira Christo P, Volpe CM. Drug Repurposing and Artificial Intelligence in Multiple Sclerosis: Emerging Strategies for Precision Therapy. Scler [Internet]. 2025;3(3):28. p.].","journal-title":"Scler [Internet]"},{"key":"4551_CR257","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.ailsci.2022.100042","volume":"2","author":"L Menestrina","year":"2022","unstructured":"Menestrina L, Recanatini M. An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington\u2019s disease and multiple sclerosis. Artif Intell Life Sci. 2022;2:100042. https:\/\/doi.org\/10.1016\/j.ailsci.2022.100042.","journal-title":"Artif Intell Life Sci"},{"issue":"9","key":"4551_CR258","first-page":"446","volume":"11","author":"DP Mihai","year":"2019","unstructured":"Mihai DP, Nitulescu GM, Ion GN, Ciotu CI, Chirita C, Negres S. Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis. Pharm [Internet]. 2019;11(9):446.","journal-title":"Pharm [Internet]"},{"key":"4551_CR259","doi-asserted-by":"crossref","unstructured":"Jiang Y, Liu Q, Stridh P, Kockum I, Olsson T, Alfredsson L et al. Multiomics integration prioritizes potential drug targets for multiple sclerosis. Proceedings of the National Academy of Sciences. 2025;122(26):e2425537122.","DOI":"10.1073\/pnas.2425537122"},{"issue":"5","key":"4551_CR260","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1021\/acschemneuro.1c00011","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Li H, Wang F, Xiao F, Yan W, Hu G. Network-based target prioritization and drug candidate identification for multiple sclerosis: from analyzing Omics Data to druggability simulations. ACS Chem Neurosci. 2021;12(5):917\u201329.","journal-title":"ACS Chem Neurosci"},{"key":"4551_CR261","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.bbrep.2022.101337","volume":"32","author":"AR Afief","year":"2022","unstructured":"Afief AR, Irham LM, Adikusuma W, Perwitasari DA, Brahmadhi A, Chong R. Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis. Biochem Biophys Rep. 2022;32:101337. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101337.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"4551_CR262","first-page":"9988405","volume":"2023","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Ma R, Chen H, Guo W, Li Z, Xu K, et al. CD86 is associated with immune infiltration and immunotherapy signatures in AML and promotes its progression. J Oncol. 2023;2023(1):9988405.","journal-title":"J Oncol"},{"issue":"7","key":"4551_CR263","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","volume":"186","author":"M Charabati","year":"2023","unstructured":"Charabati M, Wheeler MA, Weiner HL, Quintana FJ. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting. Cell. 2023;186(7):1309\u201327. https:\/\/doi.org\/10.1016\/j.cell.2023.03.008.","journal-title":"Cell"},{"key":"4551_CR264","doi-asserted-by":"crossref","unstructured":"Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296-303.10.1212\/wnl.0000000000003509.","DOI":"10.1212\/WNL.0000000000003509"},{"key":"4551_CR265","doi-asserted-by":"crossref","unstructured":"Rugg-Gunn F, Miserocchi A, McEvoy A. Epilepsy surgery. Pract Neurol. 2020;20(1):4-14.10.1136\/practneurol-2019-002192.","DOI":"10.1136\/practneurol-2019-002192"},{"key":"4551_CR266","doi-asserted-by":"crossref","unstructured":"Dy\u0144ka D, Kowalcze K, Paziewska A. The Role of Ketogenic Diet in the Treatment of Neurological Diseases. Nutrients. 2022;14(23).10.3390\/nu14235003.","DOI":"10.3390\/nu14235003"},{"key":"4551_CR267","doi-asserted-by":"crossref","unstructured":"Ryvlin P, Rheims S, Hirsch LJ, Sokolov A, Jehi L. Neuromodulation in epilepsy: state-of-the-art approved therapies. Lancet Neurol. 2021;20(12):1038\u2009\u2013\u200947.10.1016\/s1474-4422(21)00300-8.","DOI":"10.1016\/S1474-4422(21)00300-8"},{"key":"4551_CR268","doi-asserted-by":"crossref","unstructured":"Lv X, Wang J, Yuan Y, Pan L, Liu Q, Guo J. In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy. Scientific Reports. 2024;14(1):16562.10.1038\/s41598-024-67594-6.","DOI":"10.1038\/s41598-024-67594-6"},{"issue":"3","key":"4551_CR269","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/07391102.2023.2199874","volume":"42","author":"P Kumar","year":"2024","unstructured":"Kumar P, Sheokand D, Grewal A, Saini V, Kumar A. Clinical side-effects based drug repositioning for anti-epileptic activity. J Biomol Struct Dynamics. 2024;42(3):1443\u201354.","journal-title":"J Biomol Struct Dynamics"},{"key":"4551_CR270","unstructured":"Mamidala S, NeuroCADR. Drug Repurposing to Reveal Novel Anti-Epileptic Drug Candidates Through an Integrated Computational Approach. arXiv preprint arXiv:230913047. 2023."},{"key":"4551_CR271","doi-asserted-by":"crossref","unstructured":"Khan AF, Iturria-Medina Y. Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms. Translational Psychiatry. 2024;14(1):386.10.1038\/s41398-024-03073-w.","DOI":"10.1038\/s41398-024-03073-w"},{"key":"4551_CR272","doi-asserted-by":"crossref","unstructured":"Mao H, Matsubara T, Tanaka N, Peled N, Farzaneh H, Melania lon D et al. Transcriptomic decoding of regional cortical vulnerability to drug-resistant epilepsy using 7T MRI. Communications Biology. 2025;9(1):121.10.1038\/s42003-025-09397-7.","DOI":"10.1038\/s42003-025-09397-7"},{"key":"4551_CR273","doi-asserted-by":"crossref","unstructured":"Bod R, T\u00f3th K, Essam N, T\u00f3th EZ, Er\u00f5ss L, Entz L et al. Synaptic alterations and neuronal firing in human epileptic neocortical excitatory networks. Front Synaptic Neurosci. 2023;15:1233569.10.3389\/fnsyn.2023.1233569.","DOI":"10.3389\/fnsyn.2023.1233569"},{"key":"4551_CR274","doi-asserted-by":"crossref","unstructured":"Spellicy SE, Hess DC. Recycled Translation: Repurposing Drugs for Stroke. Transl Stroke Res. 2022;13(6):866\u2009\u2013\u200980.10.1007\/s12975-022-01000-z.","DOI":"10.1007\/s12975-022-01000-z"},{"key":"4551_CR275","doi-asserted-by":"crossref","unstructured":"Zivin JA. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol. 2009;66(1):6-10.10.1002\/ana.21750.","DOI":"10.1002\/ana.21750"},{"issue":"15","key":"4551_CR276","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.7150\/thno.112608","volume":"15","author":"Q Meng","year":"2025","unstructured":"Meng Q, Liu Q, Mi Y, Xu L, Wang F, Mu D, et al. Multi-dimensional data-driven computational drug repurposing strategy for screening novel neuroprotective agents in ischemic stroke. Theranostics. 2025;15(15):7653.","journal-title":"Theranostics"},{"key":"4551_CR277","doi-asserted-by":"crossref","unstructured":"Akodad S, Niu X, Secades B, Stevens H. Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation. Commun Med (Lond). 2026;6(1):84.10.1038\/s43856-025-01344-1.","DOI":"10.1038\/s43856-025-01344-1"},{"key":"4551_CR278","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/978-1-0716-4690-8_24","volume-title":"Artificial Intelligence (AI) in Cell and Genetic Engineering","author":"S Kapil","year":"2025","unstructured":"Kapil S, Bagga P. Silico Validation of AI-Assisted Drugs in Healthcare. In: Mandal S, editor. Artificial Intelligence (AI) in Cell and Genetic Engineering. New York, NY: Springer US; 2025. pp. 445\u201358."},{"issue":"10","key":"4551_CR279","doi-asserted-by":"publisher","first-page":"e42750","DOI":"10.1016\/j.heliyon.2025.e42750","volume":"11","author":"AI Trejo-Castro","year":"2025","unstructured":"Trejo-Castro AI, Martinez-Ledesma E, Martinez-Torteya A. A bibliometric review on in silico drug repurposing: Performance analysis, science mapping and text mining (2000\u20132023). Heliyon. 2025;11(10):e42750. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42750.","journal-title":"Heliyon"},{"issue":"3","key":"4551_CR280","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jpbi2030011","volume":"2","author":"DM Braga","year":"2025","unstructured":"Braga DM, Rawal BS. Harnessing AI and Quantum Computing for Accelerated Drug Discovery: Regulatory Frameworks for In Silico to In Vivo Validation. J Pharm BioTech Ind [Internet]. 2025;2(3):11.","journal-title":"J Pharm BioTech Ind [Internet]"},{"issue":"10","key":"4551_CR281","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/jpm12101731","volume":"12","author":"G Fiscon","year":"2022","unstructured":"Fiscon G, Sibilio P, Funari A, Conte F, Paci P. Identification of Potential Repurposable Drugs in Alzheimer\u2019s Disease Exploiting a Bioinformatics Analysis. J Personalized Med [Internet]. 2022;12(10):1731.","journal-title":"J Personalized Med [Internet]"},{"issue":"12","key":"4551_CR282","doi-asserted-by":"publisher","first-page":"e0338211","DOI":"10.1371\/journal.pone.0338211","volume":"20","author":"R Tanjin","year":"2025","unstructured":"Tanjin R, Al-Amin M, Etee JM, Siddika A, Siddiki A, Mahi SI, et al. An evaluation of Roluperidone as a promising repurposing candidate for Alzheimer\u2019s Disease: A Computational Investigation. PLoS ONE. 2025;20(12):e0338211.","journal-title":"PLoS ONE"},{"issue":"19","key":"4551_CR283","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.3390\/molecules27196453","volume":"27","author":"M Lazarczyk","year":"2022","unstructured":"Lazarczyk M, Duda K, Mickael ME, Ak O, Paszkiewicz J, Kowalczyk A, et al. Adera2.0: A Drug Repurposing Workflow for Neuroimmunological Investigations Using Neural Networks. Molecules [Internet]. 2022;27(19):6453.","journal-title":"Molecules [Internet]"},{"key":"4551_CR284","doi-asserted-by":"publisher","first-page":"141864","DOI":"10.1016\/j.foodchem.2024.141864","volume":"464","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang W, Abubaker MA, Shu Q, Liu Y. In silico identification and experimental validation of two types of angiotensin-converting enzyme (ACE) and xanthine oxidase (XO) milk inhibitory peptides. Food Chem. 2025;464:141864. https:\/\/doi.org\/10.1016\/j.foodchem.2024.141864.","journal-title":"Food Chem"},{"key":"4551_CR285","doi-asserted-by":"crossref","unstructured":"Badr-Eldin SM, Aldawsari HM, Kotta S, Deb PK, Venugopala KN. Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects. Pharmaceuticals (Basel). 2022;15(8).10.3390\/ph15080926.","DOI":"10.3390\/ph15080926"},{"key":"4551_CR286","doi-asserted-by":"crossref","unstructured":"Wang L, Hu D, Xu J, Hu J, Wang Y. Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine. Clin Transl Sci. 2023;17(2).10.1111\/cts.13695.","DOI":"10.1111\/cts.13695"},{"issue":"4","key":"4551_CR287","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.3390\/ijms24043232","volume":"24","author":"UMN Cao","year":"2023","unstructured":"Cao UMN, Zhang Y, Chen J, Sayson D, Pillai S, Tran SD. Microfluidic Organ-on-A-chip: A Guide to Biomaterial Choice and Fabrication. Int J Mol Sci [Internet]. 2023;24(4):3232.","journal-title":"Int J Mol Sci [Internet]"},{"key":"4551_CR288","doi-asserted-by":"crossref","unstructured":"Silva Franco L, Rodrigues DA, Baumart GJ, de Jesus BSM, Gomes FCA, Lima LM et al. Drug Repurposing by Virtual Screening: Identification of New Already Approved ROCK Inhibitors as Promising Drugs to Target Neurodegeneration. ACS Omega. 2025;10(26):28446\u2009\u2013\u200965.10.1021\/acsomega.5c04340.","DOI":"10.1021\/acsomega.5c04340"},{"key":"4551_CR289","doi-asserted-by":"crossref","unstructured":"Fang J, Zhang P, Wang Q, Chiang C-W, Zhou Y, Hou Y et al. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy. 2022;14(1):7.10.1186\/s13195-021-00951-z.","DOI":"10.1186\/s13195-021-00951-z"},{"key":"4551_CR290","doi-asserted-by":"crossref","unstructured":"Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015;33(8):1582\u2009\u2013\u2009614.10.1016\/j.biotechadv.2015.08.001.","DOI":"10.1016\/j.biotechadv.2015.08.001"},{"issue":"1","key":"4551_CR291","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/ijms24010604","volume":"24","author":"VI Pasko","year":"2023","unstructured":"Pasko VI, Churkina AS, Shakhov AS, Kotlobay AA, Alieva IB. Modeling of Neurodegenerative Diseases: \u2018Step by Step\u2019 and \u2018Network\u2019 Organization of the Complexes of Model Systems. Int J Mol Sci [Internet]. 2023;24(1):604.","journal-title":"Int J Mol Sci [Internet]"},{"issue":"10","key":"4551_CR292","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/ph18101536","volume":"18","author":"JD Ripa","year":"2025","unstructured":"Ripa JD, Ali S, Field M, Smithson J, Wangchuk P, From AI-A. Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery. Pharmaceuticals [Internet]. 2025;18(10):1536.","journal-title":"Pharmaceuticals [Internet]"},{"key":"4551_CR293","doi-asserted-by":"publisher","first-page":"116442","DOI":"10.1016\/j.biopha.2024.116442","volume":"174","author":"J-B Kim","year":"2024","unstructured":"Kim J-B, Kim S-J, So M, Kim D-K, Noh HR, Kim BJ, et al. Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of \u03b1-synuclein propagation: Implications in Parkinson\u2019s disease. Biomed Pharmacother. 2024;174:116442. https:\/\/doi.org\/10.1016\/j.biopha.2024.116442.","journal-title":"Biomed Pharmacother"},{"key":"4551_CR294","doi-asserted-by":"publisher","first-page":"109880","DOI":"10.1016\/j.neuropharm.2024.109880","volume":"248","author":"TH Johnston","year":"2024","unstructured":"Johnston TH, Lacoste AMB, Ravenscroft P, Su J, Tamadon S, Seifi M, et al. Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia. Neuropharmacology. 2024;248:109880. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109880.","journal-title":"Neuropharmacology"},{"key":"4551_CR295","doi-asserted-by":"crossref","unstructured":"Sheng J, Zhang T. Advancing drug development with Fit-for-Purpose modeling informed approaches. J Pharmacokinet Pharmacodyn. 2025;52(5):52.10.1007\/s10928-025-09995-2.","DOI":"10.1007\/s10928-025-09995-2"},{"issue":"5","key":"4551_CR296","first-page":"362","volume":"14","author":"MS Lipsky","year":"2001","unstructured":"Lipsky MS, Sharp LK. From idea to market: the drug approval process. J Am Board Fam Pract. 2001;14(5):362\u20137.","journal-title":"J Am Board Fam Pract"},{"issue":"10","key":"4551_CR297","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4155\/fmc-2019-0307","volume":"12","author":"N Berdigaliyev","year":"2020","unstructured":"Berdigaliyev N, Aljofan M. An overview of drug discovery and development. Future Med Chem. 2020;12(10):939\u201347.","journal-title":"Future Med Chem"},{"issue":"1","key":"4551_CR298","doi-asserted-by":"publisher","first-page":"1070716","DOI":"10.1155\/adpp\/1070716","volume":"2025","author":"MS Hussain","year":"2025","unstructured":"Hussain MS, Mir PA, Kumar N, Mohi-Ud-Din R, Wali AF, Mir RH, et al. From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases. Adv Pharmacol Pharm Sci. 2025;2025(1):1070716.","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"4551_CR299","doi-asserted-by":"publisher","unstructured":"Zang C, Zhang H, Xu J, Zhang H, Fouladvand S, Havaldar S, Cheng F, Chen K, Chen Y, Glicksberg BS, Chen J, Bian J, Wang F. High-throughput target trial emulation for Alzheimer's disease drug repurposing with real-world data. Nat Commun. 2023;14(1):8180. https:\/\/doi.org\/10.1038\/s41467-023-43929-1.","DOI":"10.1038\/s41467-023-43929-1"},{"key":"4551_CR300","doi-asserted-by":"crossref","unstructured":"Kshirsagar N. Post-marketing safety signals: Challenges in regulatory decisions, communication & impact evaluation in developing countries. Indian J Med Res. 2017;146(4):445\u2009\u2013\u20097.10.4103\/ijmr.IJMR_1070_17.","DOI":"10.4103\/ijmr.IJMR_1070_17"},{"key":"4551_CR301","doi-asserted-by":"publisher","unstructured":"Apolloni S, D'Ambrosi N. Repurposing niclosamide for the treatment of neurological disorders. Neural Regen Res. 2023;18(12):2705-2706. doi: https:\/\/doi.org\/10.4103\/1673-5374.373705.","DOI":"10.4103\/1673-5374.373705"},{"key":"4551_CR302","doi-asserted-by":"crossref","unstructured":"Mortberg MA, Vallabh SM, Minikel EV. Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials. Scientific Reports. 2022;12(1):17708.10.1038\/s41598-022-21820-1.","DOI":"10.1038\/s41598-022-21820-1"},{"key":"4551_CR303","doi-asserted-by":"crossref","unstructured":"Minikel EV, Painter JL, Dong CC, Nelson MR. Refining the impact of genetic evidence on clinical success. Nature. 2024;629(8012):624\u2009\u2013\u20099.10.1038\/s41586-024-07316-0.","DOI":"10.1038\/s41586-024-07316-0"},{"key":"4551_CR304","doi-asserted-by":"crossref","unstructured":"Freije I, Lamouche S, Tanguay M. Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements. Ther Innov Regul Sci. 2020;54(1):128\u2009\u2013\u200938.10.1007\/s43441-019-00036-y.","DOI":"10.1007\/s43441-019-00036-y"},{"issue":"1","key":"4551_CR305","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drudis.2018.07.005","volume":"24","author":"WF Salminen","year":"2019","unstructured":"Salminen WF, Wiles ME, Stevens RE. Streamlining nonclinical drug development using the FDA 505(b)(2) new drug application regulatory pathway. Drug Discovery Today. 2019;24(1):46\u201356. https:\/\/doi.org\/10.1016\/j.drudis.2018.07.005.","journal-title":"Drug Discovery Today"},{"issue":"4","key":"4551_CR306","doi-asserted-by":"publisher","first-page":"e00624","DOI":"10.1016\/j.neurot.2025.e00624","volume":"22","author":"S Ekins","year":"2025","unstructured":"Ekins S, Lane TR. Applications of artificial intelligence in drug discovery for neurological diseases. Neurotherapeutics. 2025;22(4):e00624. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00624.","journal-title":"Neurotherapeutics"},{"key":"4551_CR307","doi-asserted-by":"publisher","first-page":"100338","DOI":"10.1016\/j.ibmed.2025.100338","volume":"13","author":"F Afroughi","year":"2026","unstructured":"Afroughi F, SeyedAlinaghi S, Mirzapour P, Shirdel S, Parmoon Z, Khorshidi MM, et al. The potential of artificial intelligence in advancing neuroscience: A systematic review of current applications and models. Intelligence-Based Med. 2026;13:100338. https:\/\/doi.org\/10.1016\/j.ibmed.2025.100338.","journal-title":"Intelligence-Based Med"},{"issue":"4","key":"4551_CR308","doi-asserted-by":"publisher","first-page":"e44658","DOI":"10.1016\/j.heliyon.2026.e44658","volume":"12","author":"N Eissa","year":"2026","unstructured":"Eissa N, Chkier D, Ahmed A, Attia R, Zia M, Beiram R, et al. Exploring the intersecting paths between metabolic disorders and neurological manifestations. Heliyon. 2026;12(4):e44658. https:\/\/doi.org\/10.1016\/j.heliyon.2026.e44658.","journal-title":"Heliyon"},{"issue":"6","key":"4551_CR309","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/genes16060622","volume":"16","author":"B Roque-Ram\u00edrez","year":"2025","unstructured":"Roque-Ram\u00edrez B, R\u00edos-L\u00f3pez KE, L\u00f3pez-Hern\u00e1ndez LB. Decoding Neuromuscular Disorders: The Complex Role of Genetic and Epigenetic Regulators. Genes [Internet]. 2025;16(6):622.","journal-title":"Genes [Internet]"},{"key":"4551_CR310","doi-asserted-by":"crossref","unstructured":"Zhang XM, Liang L, Liu L, Tang MJ. Graph Neural Networks and Their Current Applications in Bioinformatics. Front Genet. 2021;12:690049.10.3389\/fgene.2021.690049.","DOI":"10.3389\/fgene.2021.690049"},{"key":"4551_CR311","doi-asserted-by":"publisher","unstructured":"Anokian E, Bernett J, Freeman A, List M, Santamar\u00eda LP, Tanoli Z et al. Machine Learning and Artificial Intelligence in Drug Repurposing\u2014Challenges and Perspectives. Drug repurposing. 2024;1(1). https:\/\/doi.org\/10.58647\/DRUGREPO.24.1.0004","DOI":"10.58647\/DRUGREPO.24.1.0004"},{"key":"4551_CR312","doi-asserted-by":"crossref","unstructured":"Wan Z, Sun X, Li Y, Chu T, Hao X, Cao Y et al. Applications of Artificial Intelligence in Drug Repurposing. Adv Sci (Weinh). 2025;12(14):e2411325.10.1002\/advs.202411325.","DOI":"10.1002\/advs.202411325"},{"issue":"4","key":"4551_CR313","first-page":"28","volume":"12","author":"P Keramida","year":"2025","unstructured":"Keramida P, Syrigos NK, Kouvela M, Poulakou G, Charpidou A, Fiste O. A\u0399-Driven Drug Repurposing: Appl Challenges Med. 2025;12(4):28.","journal-title":"A\u0399-Driven Drug Repurposing: Appl Challenges Med"},{"key":"4551_CR314","doi-asserted-by":"crossref","unstructured":"Zhang R, Wen H, Lin Z, Li B, Zhou X. Artificial Intelligence-Driven Drug Toxicity Prediction: Advances, Challenges, and Future Directions. Toxics. 2025;13(7).10.3390\/toxics13070525.","DOI":"10.3390\/toxics13070525"},{"issue":"13","key":"4551_CR315","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.2174\/1381612826666200224112534","volume":"26","author":"Y Morofuji","year":"2020","unstructured":"Morofuji Y, Nakagawa S. Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning. Curr Pharm Design. 2020;26(13):1466\u201385. https:\/\/doi.org\/10.2174\/1381612826666200224112534.","journal-title":"Curr Pharm Design"},{"issue":"1","key":"4551_CR316","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/fi13010014","volume":"13","author":"X Zhang","year":"2021","unstructured":"Zhang X, Che C. Drug Repurposing for Parkinson\u2019s Disease by Integrating Knowledge Graph Completion Model and Knowledge Fusion of Medical Literature. Future Internet [Internet]. 2021;13(1):14.","journal-title":"Future Internet [Internet]"},{"key":"4551_CR317","doi-asserted-by":"publisher","unstructured":"Soylu E, G\u00fcl S, Koca KA, T\u00fcrko\u011flu M, Terzi M, \u015eeng\u00fcr A. Speech signal-based accurate neurological disorders detection using convolutional neural network and recurrent neural network based deep network. Engineering Applications of Artificial Intelligence. 2025;149:110558.https:\/\/doi.org\/10.1016\/j.engappai.2025.110558","DOI":"10.1016\/j.engappai.2025.110558"},{"key":"4551_CR318","doi-asserted-by":"crossref","unstructured":"Dash S, Shakyawar SK, Sharma M, Kaushik S. Big data in healthcare: management, analysis and future prospects. Journal of Big Data. 2019;6(1):54.10.1186\/s40537-019-0217-0.","DOI":"10.1186\/s40537-019-0217-0"},{"issue":"6","key":"4551_CR319","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/s25061739","volume":"25","author":"I Abousaber","year":"2025","unstructured":"Abousaber I. A Novel Explainable Attention-Based Meta-Learning Framework for Imbalanced Brain Stroke Prediction. Sens [Internet]. 2025;25(6):1739.","journal-title":"Sens [Internet]"},{"key":"4551_CR320","doi-asserted-by":"crossref","unstructured":"D\u2019Sa K, Evans JR, Virdi GS, Vecchi G, Adam A, Bertolli O et al. Prediction of mechanistic subtypes of Parkinson\u2019s using patient-derived stem cell models. Nature Machine Intelligence. 2023;5(8):933\u2009\u2013\u200946.10.1038\/s42256-023-00702-9.","DOI":"10.1038\/s42256-023-00702-9"},{"issue":"1","key":"4551_CR321","doi-asserted-by":"publisher","first-page":"89","DOI":"10.62641\/aep.v53i1.1728","volume":"53","author":"M Yang","year":"2025","unstructured":"Yang M, Zhao Y, Yu H, Chen S, Gao G, Li D, et al. A Multi-Label Deep Learning Model for Detailed Classification of Alzheimer\u2019s Disease. Actas Esp de psiquiatria. 2025;53(1):89.","journal-title":"Actas Esp de psiquiatria"},{"key":"4551_CR322","doi-asserted-by":"crossref","unstructured":"Birkenbihl C, Emon MA, Vrooman H, Westwood S, Lovestone S, Hofmann-Apitius M et al. Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice. EPMA Journal. 2020;11(3):367\u2009\u2013\u200976.10.1007\/s13167-020-00216-z.","DOI":"10.1007\/s13167-020-00216-z"},{"key":"4551_CR323","doi-asserted-by":"crossref","unstructured":"Cui W, Leng Y, Peng Y, Bai C, Li L, Jiang X et al. A Novel Dynamic Neural Network for Heterogeneity-Aware Structural Brain Network Exploration and Alzheimer\u2019s Disease Diagnosis. IEEE Transactions on Neural Networks and Learning Systems. 2025;36(9):15764\u2009\u2013\u200978.10.1109\/TNNLS.2025.3569650.","DOI":"10.1109\/TNNLS.2025.3569650"},{"key":"4551_CR324","doi-asserted-by":"crossref","unstructured":"Ennab M, McHeick H. Enhancing interpretability and accuracy of AI models in healthcare: a comprehensive review on challenges and future directions. Front Robot AI. 2024;11:1444763.10.3389\/frobt.2024.1444763.","DOI":"10.3389\/frobt.2024.1444763"},{"key":"4551_CR325","doi-asserted-by":"crossref","unstructured":"Chakrabarty S, Bishwas P, Bandyopadhyay M, Sublime J. Can We Trust AI With Our Ears? A Cross-Domain Comparative Analysis of Explainability in Audio Intelligence. IEEE Access. 2025;13:179733-58.10.1109\/ACCESS.2025.3622161.","DOI":"10.1109\/ACCESS.2025.3622161"},{"key":"4551_CR326","doi-asserted-by":"crossref","unstructured":"Bergquist M, Rolandsson B, Gryska E, Laesser M, Hoefling N, Heckemann R et al. Trust and stakeholder perspectives on the implementation of AI tools in clinical radiology. European Radiology. 2024;34(1):338\u2009\u2013\u200947.10.1007\/s00330-023-09967-5.","DOI":"10.1007\/s00330-023-09967-5"},{"key":"4551_CR327","doi-asserted-by":"crossref","unstructured":"Bloch L, Friedrich CM. for the Alzheimer\u2019s Disease Neuroimaging I. Machine Learning Workflow to Explain Black-Box Models for Early Alzheimer\u2019s Disease Classification Evaluated for Multiple Datasets. SN Computer Science. 2022;3(6):509.10.1007\/s42979-022-01371-y.","DOI":"10.1007\/s42979-022-01371-y"},{"issue":"8","key":"4551_CR328","doi-asserted-by":"publisher","first-page":"e0289495","DOI":"10.1371\/journal.pone.0289495","volume":"18","author":"M Hernandez","year":"2023","unstructured":"Hernandez M, Ramon-Julvez U, Vilades E, Cordon B, Mayordomo E, Garcia-Martin E. Explainable artificial intelligence toward usable and trustworthy computer-aided diagnosis of multiple sclerosis from Optical Coherence Tomography. PLoS ONE. 2023;18(8):e0289495.","journal-title":"PLoS ONE"},{"key":"4551_CR329","doi-asserted-by":"crossref","unstructured":"Mittermaier M, Raza MM, Kvedar JC. Bias in AI-based models for medical applications: challenges and mitigation strategies. npj Digital Medicine. 2023;6(1):113.10.1038\/s41746-023-00858-z.","DOI":"10.1038\/s41746-023-00858-z"},{"key":"4551_CR330","doi-asserted-by":"crossref","unstructured":"Wang T, Zhang K, Cai J, Gong Y, Choo K-KR, Guo Y. Analyzing the Impact of Personalization on Fairness in Federated Learning for Healthcare. Journal of Healthcare Informatics Research. 2024;8(2):181-205.10.1007\/s41666-024-00164-7.","DOI":"10.1007\/s41666-024-00164-7"},{"key":"4551_CR331","doi-asserted-by":"crossref","unstructured":"Xu J, Xiao Y, Wang WH, Ning Y, Shenkman EA, Bian J et al. Algorithmic fairness in computational medicine. eBioMedicine. 2022;84.10.1016\/j.ebiom.2022.104250.","DOI":"10.1016\/j.ebiom.2022.104250"},{"key":"4551_CR332","doi-asserted-by":"crossref","unstructured":"Kanauzia R, Singh M, Gulati S, Singh BM, Arora N, Gola KK. A comprehensive survey on federated learning for privacy preservation in digital healthcare applications. Knowledge and Information Systems. 2026;68(1):55.10.1007\/s10115-025-02673-2.","DOI":"10.1007\/s10115-025-02673-2"},{"issue":"21","key":"4551_CR333","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1212\/WNL.0000000000012884","volume":"97","author":"H Vrenken","year":"2021","unstructured":"Vrenken H, Jenkinson M, Pham DL, Guttmann CRG, Pareto D, Paardekooper M, et al. Opportunities for Understanding MS Mechanisms and Progression With MRI Using Large-Scale Data Sharing and Artificial Intelligence. Neurology. 2021;97(21):989\u201399. https:\/\/doi.org\/10.1212\/WNL.0000000000012884.","journal-title":"Neurology"},{"key":"4551_CR334","doi-asserted-by":"publisher","unstructured":"Aittokallio T. What are the current challenges for machine learning in drug discovery and repurposing? Expert Opin Drug Discov. 2022;17(5):423-425. https:\/\/doi.org\/10.1080\/17460441.2022.2050694.","DOI":"10.1080\/17460441.2022.2050694"},{"key":"4551_CR335","doi-asserted-by":"crossref","unstructured":"AlSaad R, Abd-Alrazaq A, Boughorbel S, Ahmed A, Renault MA, Damseh R et al. Multimodal Large Language Models in Health Care: Applications, Challenges, and Future Outlook. J Med Internet Res. 2024;26:e59505.10.2196\/59505.","DOI":"10.2196\/59505"},{"key":"4551_CR336","doi-asserted-by":"crossref","unstructured":"Suri GS, Kaur G, Shinde D. Beyond boundaries: exploring the transformative power of AI in pharmaceuticals. Discover Artificial Intelligence. 2024;4(1):82.10.1007\/s44163-024-00192-7.","DOI":"10.1007\/s44163-024-00192-7"},{"issue":"1","key":"4551_CR337","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/ph18010047","volume":"18","author":"F Mirakhori","year":"2025","unstructured":"Mirakhori F, Niazi SK. Harnessing the AI\/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective. Pharmaceuticals [Internet]. 2025;18(1):47.","journal-title":"Pharmaceuticals [Internet]"},{"key":"4551_CR338","doi-asserted-by":"crossref","unstructured":"an de Sande D, Van Genderen ME, Smit JM, Huiskens J, Visser JJ, Veen RER et al. Developing, implementing and governing artificial intelligence in medicine: a step-by-step approach to prevent an artificial intelligence winter. BMJ Health & Care Informatics. 2022;29(1):e100495.10.1136\/bmjhci-2021-100495.","DOI":"10.1136\/bmjhci-2021-100495"},{"issue":"6","key":"4551_CR339","doi-asserted-by":"publisher","first-page":"e0000278","DOI":"10.1371\/journal.pdig.0000278","volume":"2","author":"LH Nazer","year":"2023","unstructured":"Nazer LH, Zatarah R, Waldrip S, Ke JXC, Moukheiber M, Khanna AK, et al. Bias in artificial intelligence algorithms and recommendations for mitigation. PLOS Digit health. 2023;2(6):e0000278.","journal-title":"PLOS Digit health"},{"key":"4551_CR340","doi-asserted-by":"crossref","unstructured":"Chong PL, Vaigeshwari V, Mohammed Reyasudin BK, Noor Hidayah BRA, Tatchanaamoorti P, Yeow JA et al. Integrating artificial intelligence in healthcare: applications, challenges, and future directions. Future Sci OA. 2025;11(1):2527505.10.1080\/20565623.2025.2527505.","DOI":"10.1080\/20565623.2025.2527505"},{"key":"4551_CR341","doi-asserted-by":"crossref","unstructured":"Maleki Varnosfaderani S, Forouzanfar M. The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengineering (Basel). 2024;11(4).10.3390\/bioengineering11040337.","DOI":"10.3390\/bioengineering11040337"},{"key":"4551_CR342","doi-asserted-by":"publisher","first-page":"1537462","DOI":"10.3389\/fncel.2025.1537462","volume":"19","author":"O Krejcar","year":"2025","unstructured":"Krejcar O, Namazi H. Multiscale brain modeling: bridging microscopic and macroscopic brain dynamics for clinical and technological applications. Front Cell Neurosci. 2025;19:1537462.","journal-title":"Front Cell Neurosci"},{"key":"4551_CR343","doi-asserted-by":"publisher","unstructured":"Manin AF, Gambarova LR, Gasparyan MA, Usmanova LR, Marshukov IA, Bartenev AD et al. Personalized medicine and artificial intelligence in neurology: An individual approach to diagnosis and treatment. Cardiometry. 2024(31):47\u201353. https:\/\/doi.org\/10.18137\/cardiometry.2024.31.4753.","DOI":"10.18137\/cardiometry.2024.31.4753"},{"issue":"20","key":"4551_CR344","doi-asserted-by":"publisher","first-page":"9305","DOI":"10.3390\/app14209305","volume":"14","author":"A Trezza","year":"2024","unstructured":"Trezza A, Visibelli A, Roncaglia B, Spiga O, Santucci A. Unsupervised Learning in Precision Medicine: Unlocking Personalized Healthcare through AI. Appl Sci [Internet]. 2024;14(20):9305. p.].","journal-title":"Appl Sci [Internet]"},{"key":"4551_CR345","doi-asserted-by":"crossref","unstructured":"Fahim YA, Hasani IW, Kabba S, Ragab WM. Artificial intelligence in healthcare and medicine: clinical applications, therapeutic advances, and future perspectives. Eur J Med Res. 2025;30(1):848.10.1186\/s40001-025-03196-w.","DOI":"10.1186\/s40001-025-03196-w"},{"issue":"12","key":"4551_CR346","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/brainsci14121266","volume":"14","author":"R Kumar","year":"2024","unstructured":"Kumar R, Waisberg E, Ong J, Paladugu P, Amiri D, Saintyl J, et al. Artificial Intelligence-Based Methodologies for Early Diagnostic Precision and Personalized Therapeutic Strategies in Neuro-Ophthalmic and Neurodegenerative Pathologies. Brain Sci [Internet]. 2024;14(12):1266.","journal-title":"Brain Sci [Internet]"},{"issue":"1","key":"4551_CR347","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3171\/2023.5.JNS23982","volume":"140","author":"AI Yang","year":"2024","unstructured":"Yang AI, Isbaine F, Alwaki A, Gross RE. Multitarget deep brain stimulation for epilepsy. J Neurosurg. 2024;140(1):210\u20137. https:\/\/doi.org\/10.3171\/2023.5.JNS23982.","journal-title":"J Neurosurg"},{"key":"4551_CR348","doi-asserted-by":"crossref","unstructured":"Chaparro-C\u00e1rdenas SL, Ramirez-Bautista JA, Terven J, C\u00f3rdova-Esparza DM, Romero-Gonzalez JA, Ram\u00edrez-Pedraza A et al. A Technological Review of Digital Twins and Artificial Intelligence for Personalized and Predictive Healthcare. Healthcare (Basel). 2025;13(14).10.3390\/healthcare13141763.","DOI":"10.3390\/healthcare13141763"},{"issue":"8","key":"4551_CR349","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/jpm12081255","volume":"12","author":"P Armeni","year":"2022","unstructured":"Armeni P, Polat I, De Rossi LM, Diaferia L, Meregalli S, Gatti A. Digital Twins in Healthcare: Is It the Beginning of a New Era of Evidence-Based Medicine? A Critical Review. J Personalized Med [Internet]. 2022;12(8):1255.","journal-title":"J Personalized Med [Internet]"},{"key":"4551_CR350","doi-asserted-by":"crossref","unstructured":"Cellina M, C\u00e8 M, Al\u00ec M, Irmici G, Ibba S, Caloro E et al. Digital Twins: The New Frontier for Personalized Medicine? Applied Sciences [Internet]. 2023; 13(13):[7940 p.].","DOI":"10.3390\/app13137940"},{"key":"4551_CR351","doi-asserted-by":"crossref","unstructured":"Nadeem M, Kostic S, Dornh\u00f6fer M, Weber C, Fathi M. A comprehensive review of digital twin in healthcare in the scope of simulative health-monitoring. Digit Health. 2025;11:20552076241304078.10.1177\/20552076241304078.","DOI":"10.1177\/20552076241304078"},{"key":"4551_CR352","doi-asserted-by":"crossref","unstructured":"Planche V, Manjon JV, Mansencal B, Lanuza E, Tourdias T, Catheline G et al. Structural progression of Alzheimer\u2019s disease over decades: the MRI staging scheme. Brain Communications. 2022;4(3).10.1093\/braincomms\/fcac109.","DOI":"10.1093\/braincomms\/fcac109"},{"key":"4551_CR353","unstructured":"Gabitto MI, Travaglini KJ, Rachleff VM, Kaplan ES, Long B, Ariza J et al. Integrated multimodal cell atlas of Alzheimer\u2019s disease. Nature Neuroscience. 2024;27(12):2366\u2009\u2013\u200983.10.1038\/s41593-024-01774-5."},{"key":"4551_CR354","doi-asserted-by":"crossref","unstructured":"Jirsa V, Wang H, Triebkorn P, Hashemi M, Jha J, Gonzalez-Martinez J et al. Personalised virtual brain models in epilepsy. The Lancet Neurology. 2023;22(5):443\u2009\u2013\u200954.10.1016\/S1474-4422(23)00008-X.","DOI":"10.1016\/S1474-4422(23)00008-X"},{"key":"4551_CR355","doi-asserted-by":"crossref","unstructured":"Goshisht MK. Machine Learning and Deep Learning in Synthetic Biology: Key Architectures, Applications, and Challenges. ACS Omega. 2024;9(9):9921\u2009\u2013\u200945.10.1021\/acsomega.3c05913.","DOI":"10.1021\/acsomega.3c05913"},{"key":"4551_CR356","doi-asserted-by":"crossref","unstructured":"Tripathi MK, Nath A, Singh TP, Ethayathulla AS, Kaur P. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Molecular Diversity. 2021;25(3):1439\u2009\u2013\u200960.10.1007\/s11030-021-10256-w.","DOI":"10.1007\/s11030-021-10256-w"},{"key":"4551_CR357","doi-asserted-by":"crossref","unstructured":"Luo X, Ding Y, Cao Y, Liu Z, Zhang W, Zeng S et al. Few-shot meta-learning applied to whole brain activity maps improves systems neuropharmacology and drug discovery. iScience. 2024;27(10).10.1016\/j.isci.2024.110875.","DOI":"10.1016\/j.isci.2024.110875"},{"key":"4551_CR358","unstructured":"McMahan B, Moore E, Ramage D, Hampson S, y, Arcas BA, editors. Communication-efficient learning of deep networks from decentralized data. Artificial intelligence and statistics; 2017: PMLR."},{"key":"4551_CR359","doi-asserted-by":"crossref","unstructured":"Wen J, Zhang Z, Lan Y, Cui Z, Cai J, Zhang W. A survey on federated learning: challenges and applications. International Journal of Machine Learning and Cybernetics. 2023;14(2):513\u2009\u2013\u200935.10.1007\/s13042-022-01647-y.","DOI":"10.1007\/s13042-022-01647-y"},{"key":"4551_CR360","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-031-88497-9_2","volume-title":"Secondary Use of Electronic Health Data: Public Health Perspectives, Use Cases and Challenges","author":"F Cascini","year":"2025","unstructured":"Cascini F. Electronic Health Data Reuse Purposes. In: Cascini F, editor. Secondary Use of Electronic Health Data: Public Health Perspectives, Use Cases and Challenges. Cham: Springer Nature Switzerland; 2025. pp. 51\u2013100."},{"key":"4551_CR361","doi-asserted-by":"crossref","unstructured":"Zong N, Wen A, Moon S, Fu S, Wang L, Zhao Y et al. Computational drug repurposing based on electronic health records: a scoping review. npj Digital Medicine. 2022;5(1):77.10.1038\/s41746-022-00617-6.","DOI":"10.1038\/s41746-022-00617-6"},{"key":"4551_CR362","doi-asserted-by":"crossref","unstructured":"Du Y, Jamasb AR, Guo J, Fu T, Harris C, Wang Y et al. Machine learning-aided generative molecular design. Nature Machine Intelligence. 2024;6(6):589-604.10.1038\/s42256-024-00843-5.","DOI":"10.1038\/s42256-024-00843-5"},{"issue":"2","key":"4551_CR363","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/picr.picr_70_24","volume":"16","author":"K Saranraj","year":"2025","unstructured":"Saranraj K, Kiran PU. Drug repurposing: Clinical practices and regulatory pathways. Perspect Clin Res. 2025;16(2):61\u20138.","journal-title":"Perspect Clin Res"},{"issue":"3","key":"4551_CR364","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.drudis.2018.11.022","volume":"24","author":"P Polamreddy","year":"2019","unstructured":"Polamreddy P, Gattu N. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions. Drug Discovery Today. 2019;24(3):789\u201395. https:\/\/doi.org\/10.1016\/j.drudis.2018.11.022.","journal-title":"Drug Discovery Today"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04551-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:08:05Z","timestamp":1787213285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":364,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4551"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04551-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declartions"}}],"article-number":"790"}}